Analyte sensor and sensing method featuring dual detection of glucose and ketones

Abstract

To provide an analyte sensor and a sensing method featuring dual detection of glucose and ketones.SOLUTION: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together by using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, and a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system including at least two enzymes that are capable of acting in concert to facilitate detection of ketones.SELECTED DRAWING: Figure 2A

Description

[Technical field]

[0001] The present invention relates to an analyte sensor and method featuring dual detection of glucose and ketones. [Background technology]

[0002] Detection of various analytes in an individual can be essential to monitor the state of health. Deviations from normal analyte levels are often indicative of an underlying physiological condition, such as a metabolic condition or disease, or exposure to a particular environmental condition. While a single analyte may be dysregulated alone for a particular physiological condition, multiple analytes may be dysregulated simultaneously due to the same physiological condition or as a result of coexisting (related) physiological conditions. When multiple analytes are dysregulated simultaneously, the degree of dysregulation may vary from analyte to analyte. Thus, monitoring of each analyte may be necessary to fully assess an individual's health status.

[0003] Periodic ex vivo analyte monitoring using collected bodily fluids may be sufficient to observe certain physiological conditions in many individuals. However, ex vivo analyte monitoring may be inconvenient or painful for some individuals, especially if bodily fluid sampling is required to be performed significantly more frequently (e.g., several times per day). Continuous analyte monitoring using implanted in vivo analyte sensors may be a more desirable approach for individuals with severe analyte dysregulation and / or rapidly fluctuating analyte levels, but may also be beneficial to other individuals due to the convenience offered. Subcutaneous, interstitial, or dermal analyte sensors can often provide sufficient measurement accuracy while minimizing user discomfort.

[0004] The following figures are included to illustrate certain aspects of the present disclosure and should not be considered as exclusive embodiments. The disclosed subject matter is capable of considerable modification, alterations, combinations, and equivalents in form and function without departing from the scope of the present disclosure. Summary of the Invention [Problem to be solved by the invention]

[0005] Many analytes are interesting targets for physiological analysis if appropriate detection chemistries can be identified. To this end, amperometric sensors configured to assay glucose in vivo have been developed and improved in recent years to facilitate monitoring of the health of diabetic patients. Other analytes commonly subject to co-dysregulation with glucose in diabetic patients include, for example, lactate, oxygen, pH, Ale, ketones, etc. Sensors configured to detect analytes commonly dysregulated in combination with glucose are known but currently have not been significantly improved.

[0006] In vivo analyte sensors are typically configured to analyze a single analyte to provide a specific analysis, often using an enzyme to provide high specificity for a given analyte. Because of such analytical specificity, current in vivo analyte sensors configured to analyze glucose are generally not effective for assaying other analytes that are frequently dysregulated in combination with glucose or result from dysregulated glucose levels. At best, current analyte monitoring approaches require a diabetic patient to wear two different in vivo analyte sensors; one configured to analyze glucose and one configured to analyze another analyte of interest, such as lactate or ketones. Analyte monitoring approaches that use multiple in vivo analyte sensors can be very inconvenient for users. Additionally, when multiple in vivo analyte sensors are used, there is an additional cost burden of equipment and a statistically increased likelihood that at least one of the individual in vivo analyte sensors will fail. [Means for solving the problem]

[0007] The present disclosure describes analyte sensors that use multiple enzymes to detect two different analytes in general, and more particularly, analyte sensors that use multiple enzymes to detect glucose and ketones, and their corresponding methods of use.

[0008] As noted above, analyte sensors using enzymes are commonly used to detect a single analyte, such as glucose or related analytes, due to the frequent specificity of enzymes for a particular substrate or class of substrates. However, monitoring multiple analytes can be complicated by the need to use a corresponding number of analyte sensors to facilitate individual detection of each analyte. This approach can be problematic or undesirable, especially when monitoring multiple analytes in vivo, due to issues such as the cost of multiple analyte sensors, user discomfort when wearing multiple analyte sensors, and an increased statistical likelihood of analyte sensor failure for an individual.

[0009] The present invention provides an analyte sensor that responds to both glucose and ketones, two analytes that are commonly dysregulated in diabetic patients. In diabetic patients who also exhibit ketoacidosis (ketone dysregulation), the concentrations of glucose and ketones may not directly correlate with each other, so using the analyte sensor disclosed herein to simultaneously monitor both analytes may be advantageous and may lead to improved health outcomes. In addition to providing health benefits to diabetic patients, the analyte sensor may also be beneficial to other individuals who wish to monitor ketone levels, such as individuals following a ketogenic diet. A ketogenic diet can be beneficial not only to promote weight loss, but also to help individuals with epilepsy manage their condition. Simultaneous glucose monitoring during ketogenic diet monitoring may provide related advantages.

[0010] In particular, the present invention allows for the use of a single analyte sensor to monitor both analytes to identify possible dysregulation by providing an analyte sensor in which the glucose-responsive active region and the ketone-responsive active region are present within the tail of a single analyte sensor. As is evident from the above discussion, simultaneous detection of glucose and ketones using a single analyte sensor may provide several advantages over monitoring approaches using separate analyte sensors. As described below, various physical arrangements of the glucose-responsive active region and the ketone-responsive active region are possible within the analyte sensor. Certain embodiments of the present disclosure include sensor designs that can interrogate the glucose-responsive active region and the ketone-responsive active region separately to determine the concentration of each analyte, such as through placing the active regions on separate working electrodes. As discussed below, there are challenges associated with incorporating active regions featuring different detection chemistries on a single analyte sensor that are addressed by the present disclosure. [Brief description of the drawings]

[0011] [Figure 1] FIG. 1 is a diagram of an exemplary detection system that can incorporate an analyte sensor of the present invention. [Figure 2A] FIG. 1 illustrates a particular enzyme system that can be used to detect ketones in accordance with the present disclosure. [Figure 2B] FIG. 1 illustrates a particular enzyme system that can be used to detect ketones in accordance with the present disclosure. [Figure 2C] FIG. 1 illustrates a particular enzyme system that can be used to detect ketones in accordance with the present disclosure. [Figure 3A] FIG. 2 is a cross-sectional view of an analyte sensor having a glucose-responsive active area and a ketone-responsive active area on a single working electrode. [Figure 3B] FIG. 2 is a cross-sectional view of an analyte sensor having a glucose-responsive active area and a ketone-responsive active area on a single working electrode. [Figure 3C] FIG. 2 is a cross-sectional view of an analyte sensor having a glucose-responsive active area and a ketone-responsive active area on a single working electrode. [Figure 4] FIG. 2 is a cross-sectional view of an analyte sensor having glucose-responsive active areas and ketone-responsive active areas on separate working electrodes. [Figure 5A] FIG. 1 is a perspective view of an analyte sensor featuring generally cylindrical electrodes arranged concentrically with respect to one another. [Figure 5B] FIG. 1 is a perspective view of an analyte sensor featuring generally cylindrical electrodes arranged concentrically with respect to one another. [Figure 5C] FIG. 1 is a perspective view of an analyte sensor featuring generally cylindrical electrodes arranged concentrically with respect to one another. [Figure 5D] FIG. 1 is a perspective view of an analyte sensor featuring generally cylindrical electrodes arranged concentrically with respect to one another. [Figure 6] Graph showing four replicates of the response of an electrode containing diaphorase, NAD+, and β-hydroxybutyrate dehydrogenase when exposed to various β-hydroxybutyrate concentrations. [Figure 7] 7 is a graph showing an exemplary plot of β-hydroxybutyrate concentration versus average current response of the electrodes of FIG. 6. [Figure 8] 7 is a graph showing an exemplary plot of the current response of the electrode of FIG. 6 upon exposure to 8 mM β-hydroxybutyrate in 100 mM PBS at 33° C. for two weeks. [Figure 9] Graph showing an exemplary plot of the response of an analyte sensor including glucose-responsive active areas and ketone-responsive active areas disposed on separate working electrodes after exposure to 30 mM glucose and 10 mM ketone. [Figure 10] Graph showing exemplary plots of the response of an analyte sensor having glucose-responsive active regions and ketone-responsive active regions at various concentrations of glucose and β-hydroxybutyrate. [Figure 11] Graph showing exemplary plots of the response of an analyte sensor having glucose-responsive active regions and ketone-responsive active regions at various concentrations of glucose and β-hydroxybutyrate. [Figure 12]Graph showing exemplary plots of the response of an analyte sensor having glucose-responsive active regions and ketone-responsive active regions at various concentrations of glucose and β-hydroxybutyrate. [Figure 13A] Graph showing four replicates of the response of an electrode containing NADHOx, NAD+, and β-hydroxybutyrate dehydrogenase when exposed to various β-hydroxybutyrate concentrations. [Figure 13B] Graph showing four replicates of the response of an electrode containing NADHOx, NAD+, and β-hydroxybutyrate dehydrogenase when exposed to various β-hydroxybutyrate concentrations. [Figure 14] 1 shows exemplary plots of current response versus time for electrodes containing NADHOx, NAD+, and β-hydroxybutyrate dehydrogenase after exposure to increasing concentrations of β-hydroxybutyrate dehydrogenase. [Figure 15A] Graph showing current response of a carbon working electrode. [Figure 15B] Graph showing the current response of carbon nanotube working electrodes containing poly-1,10-phenanthroline-5,6-dione and β-hydroxybutyrate dehydrogenase, respectively. [Figure 16] FIG. 1 illustrates a schematic of an exemplary analyte monitoring and vehicle control system in accordance with one or more embodiments of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] Glucose-responsive analyte sensors, while well-studied, are still a developing field to help diabetic patients better manage their health. Despite the prevalence of comorbid analyte dysregulation in diabetic patients, sensor chemistries suitable for detecting ketones and other analytes that are commonly dysregulated in combination with glucose have lagged significantly behind better-developed glucose detection chemistries. The present disclosure alleviates this deficiency by providing sensor chemistries suitable for detecting ketones with good response stability over a range of ketone concentrations, particularly detection chemistries that utilize an enzyme system that includes at least two enzymes that can act in concert to facilitate the detection of ketones. As used herein, the term "in concert" refers to a pair of enzyme reactions, where the product of a first enzyme reaction is the substrate for a second enzyme reaction, and the second enzyme reaction serves as the basis for measuring the concentration of the substrate (analyte) reacted during the first enzyme reaction. Although defined in terms of two paired enzyme reactions, it should be understood that in some cases, three or more enzyme reactions can be paired as well. For example, the product of a first enzymatic reaction can be a substrate for a second enzymatic reaction, and the product of the second enzymatic reaction can be a substrate for a third enzymatic reaction, which serves as a basis for measuring the concentration of the substrate (analyte) reacted during the first enzymatic reaction. A discussion of suitable enzyme systems for detecting ketones according to the disclosure herein follows below.

[0013] In cases where a single enzyme cannot facilitate detection, it may be desirable to utilize two or more enzymes acting in concert with each other to detect a given analyte of interest. Circumstances in which a single enzyme may be ineffective in facilitating detection of an analyte include, for example, situations in which the enzyme is inhibited by one or more products of the enzymatic reaction or is unable to cycle between oxidized and reduced states when placed in an analyte sensor. Some products generated by a single enzyme may not be amenable to electrochemical detection.

[0014] Even with the appropriate detection chemistry in hand, combining glucose-responsive and ketone-responsive active regions on a single analyte sensor is not a simple task. Glucose-responsive analyte sensors generally use a membrane covering the glucose-responsive active region to act as a mass transport limiting membrane and / or to improve biocompatibility. Restricting glucose access to the glucose-responsive active region with a mass transport limiting membrane can help avoid overloading (saturation) of the sensor, thereby improving detection performance and accuracy. The mass transport limiting membrane can act as a diffusion-limiting barrier to slow down the rate of mass transfer of glucose to achieve the foregoing. The mass transport limiting membrane can be homogenous and can include a single membrane polymer in conventional glucose-responsive sensors. Unfortunately, glucose and ketones exhibit significantly different permeability values ​​for a particular membrane material. Thus, when a single mass transport limiting membrane covers the active region of an analyte sensor capable of detecting both glucose and ketones, significantly different sensitivities for each analyte can be achieved, thereby complicating the ability to accurately detect glucose and ketones simultaneously. The issue of analyte sensitivity could in principle be addressed by adjusting the membrane thickness or varying the size of the active area relative to one another, but these solutions can be difficult to implement in practice.

[0015] In response to the above, the present invention also provides a membrane composition suitable for facilitating simultaneous detection of glucose and ketones and a method for its deposition. Specifically, the present disclosure provides a membrane composition having different permeability values ​​that can be separately disposed as separate compositions on the glucose-responsive active area and the ketone-responsive active area. Surprisingly, a membrane polymer suitable for use as a mass-transport limiting membrane of a glucose-responsive analyte sensor can also be suitably incorporated into a multi-component mass-transport limiting membrane for covering the active area of ​​a ketone-responsive analyte sensor, even if the membrane polymer itself is otherwise not suitable for use with ketones due to poor performance (e.g., undesirable permeability values). Advantageously, the design of the analyte sensor disclosed herein allows for a continuous membrane having a homogenous membrane portion to be disposed on the glucose-responsive active area of ​​the analyte sensor and a multi-component membrane portion to be disposed on the ketone-responsive active area. This allows for the permeability of each analyte to be simultaneously equalized, improving sensitivity and detection accuracy. As used herein, the term "homogeneous membrane" refers to a membrane made of a single type of membrane polymer, and the term "multi-component membrane" refers to a membrane made of two or more types of membrane polymers. Both bilayer and mixed membranes may be suitable for use as multi-component membranes in the present disclosure. By using multi-component membranes in combination with the sensor designs disclosed herein, manufacturing advantages can be realized when combining glucose-responsive and ketone-responsive detection chemistries with each other, compared to manufacturing approaches that modify the membrane thickness and / or active area size to adjust the sensitivity of one of the analytes.

[0016] Before describing the analyte sensors of the present disclosure in further detail, a brief overview of suitable in vivo analyte sensor configurations and sensor systems using analyte sensors will first be provided so that embodiments of the present disclosure can be better understood. FIG. 1 shows a diagram of an exemplary detection system that can incorporate the analyte sensors of the present disclosure, more particularly, analyte sensors including glucose-responsive active regions and ketone-responsive active regions. As shown, the detection system 100 comprises a sensor control device 102 and a reading device 120 configured to communicate with each other via a local communication path or link that is wired or wireless, unidirectional or bidirectional, and encrypted or unencrypted. The reading device 120, according to some embodiments, can configure an output medium for displaying the analyte concentration and alerts or notifications determined by the sensor 104 or its associated processor, as well as allowing for one or more user inputs. The reading device 120 can be a general-purpose smartphone or a dedicated electronic reading device. Although only one reading device 120 is shown, in some cases, there may be multiple reading devices 120. The reading device 120 may also communicate with the remote terminal 170 and / or the trusted computer system 180 via communication paths / links 141 and / or 142, which may be wired or wireless, single or bidirectional, and encrypted or unencrypted, respectively. The reading device 120 may additionally or alternatively communicate with a network 150 (e.g., a cellular network, the Internet, or a cloud server) via communication path / link 151. The network 150 may be further communicatively coupled to the remote terminal 170 via communication path / link 152 and / or to the trusted computer system 180 via communication path / link 153. Alternatively, the sensor 104 may communicate directly with the remote terminal 170 and / or the trusted computer system 180 without the presence of an intervening reading device 120.For example, the sensor 104 may communicate with the remote terminal 170 and / or the trusted computer system 180 via a direct communication link to the network 150, according to some embodiments, as described in U.S. Patent Application Publication No. 2011 / 0213225, which is incorporated herein by reference in its entirety. Any suitable electronic communication protocol, such as near field communication (NFC), radio frequency identification (RFID), BLUETOOTH® or BLUETOOTH® low energy protocol, WiFi®, etc., may be used for each of the communication paths or links. The remote terminal 170 and / or the trusted computer system 180 may be accessible by individuals other than the primary user who are interested in the user's analyte levels, according to some embodiments. The reading device 120 may have a display 122 and optional input components 121. The display 122 may include a touch screen interface, according to some embodiments. The sensor control device 102 includes a sensor housing 103, which may house circuitry and a power source for operating the sensor 104. Optionally, a power source and / or active circuitry may be omitted. A processor (not shown) may be communicatively coupled to the sensor 104, the processor being physically located within the sensor housing 103 or the reading device 120. The sensor 104 protrudes from an underside of the sensor housing 103 and extends through an adhesive layer 105, which, according to some embodiments, is suitable for adhering the sensor housing 103 to a tissue surface, such as the skin. The sensor 104 is adapted to be at least partially inserted into a tissue of interest, such as into the dermis or subcutaneous layer of the skin. The sensor 104 may have a sensor tail of sufficient length to insert to a desired depth of a given tissue. The sensor tail has at least one working electrode and glucose-responsive and ketone-responsive active areas on a surface of the at least one working electrode to facilitate detection of these analytes. A counter electrode may be present in combination with the at least one working electrode.The particular electrode configuration on the sensor tail is described in more detail below with reference to Figures 3A-5D.

[0017] One or more mass transport limiting membranes can coat the glucose-responsive active area and the ketone-responsive active area on at least one working electrode, as described in further detail below. The glucose-responsive active area can include a glucose-responsive enzyme, and the ketone-responsive active area can have an enzyme system including at least two enzymes that can act in concert to facilitate detection of ketones. Suitable enzyme systems are described further below with reference to FIGS. 2A-2C. According to various embodiments, the glucose-responsive active area and the ketone-responsive active area can each include a polymer to which at least some enzymes are covalently attached. In various embodiments of the present disclosure, glucose and ketones can be monitored in any biological fluid of interest, such as dermal fluid, interstitial fluid, plasma, blood, lymphatic fluid, synovial fluid, cerebrospinal fluid, saliva, bronchoalveolar lavage fluid, amniotic fluid, etc. In certain embodiments, the analyte sensor of the present disclosure can be adapted to assay dermal fluid or interstitial fluid to determine glucose and / or ketone concentrations in vivo.

[0018] With further reference to FIG. 1 , the sensor 104 may automatically transfer data to the reading device 120. For example, analyte concentration data (i.e., glucose and / or ketone concentrations) may be communicated automatically and periodically, such as at a particular frequency when the data is acquired or after a particular period of time has passed, with the data stored in memory until transmission (e.g., every minute, every five minutes, or other predetermined period of time). In other embodiments, the sensor 104 may communicate with the reading device 120 in a non-automatic manner rather than according to a set schedule. For example, RFID technology may be used to communicate data from the sensor 104 when the sensor electronics are brought within communication range of the reading device 120. The data may remain stored in the memory of the sensor 104 until communicated to the reading device 120. Thus, the user need not be in constant proximity to the reading device 120, but may instead upload data at their convenience. In still other embodiments, a combination of automatic and non-automatic data transfer may be implemented. For example, data transfer may continue automatically until the reading device 120 is no longer within communication range of the sensor 104.

[0019] The introducer may be present temporarily to facilitate the introduction of the sensor 104 into the tissue. In an exemplary embodiment, the introducer may include a needle or similar sharp. It should be appreciated that in alternative embodiments, other types of introducers, such as a sheath or blade, may be present. More specifically, the needle or other introducer may be present temporarily in proximity to the sensor 104 prior to tissue insertion and then withdrawn. While present, the needle or other introducer may facilitate the insertion of the sensor 104 into the tissue by opening an access path for the sensor 104 to follow. For example, according to one or more embodiments, the needle may facilitate the penetration of the epidermis as an access path to the dermis to allow the implantation of the sensor 104 to occur. After the access path is opened, the needle or other introducer may be withdrawn to avoid posing a sharps hazard. In an exemplary embodiment, a suitable needle may be solid or hollow, beveled or non-beveled, and / or circular or non-circular in cross section. In more particular embodiments, suitable needles may be comparable in cross-sectional diameter and / or tip design to acupuncture needles, which may have a cross-sectional diameter of about 250 microns. However, it should be recognized that suitable needles may have larger or smaller cross-sectional diameters as required for a particular application.

[0020] In some embodiments, the tip of the needle (when present) can be angled over the end of the sensor 104 so that the needle penetrates the tissue first, opening an access path for the sensor 104. In other exemplary embodiments, the sensor 104 can reside within a lumen or channel of the needle, which similarly opens an access path for the sensor 104. In either case, after facilitating insertion of the sensor, the needle is removed.

[0021] 2A-2C, a particular enzyme system that can be used to detect ketones in accordance with the disclosure herein is described in further detail. In the enzymatic reaction shown, β-hydroxybutyrate functions as a surrogate for ketones formed in vivo. As shown in FIG. 2A, one pair of cooperating enzymes that can be used to detect ketones in accordance with the disclosure herein are β-hydroxybutyrate dehydrogenase (HBDH) and diaphorase, which can be deposited within a ketone-responsive active area on at least one working electrode surface, as further described herein. When the ketone-responsive active area contains this pair of cooperating enzymes, β-hydroxybutyrate dehydrogenase catalyzes the synthesis of β-hydroxybutyrate and oxidized nicotinamide adenine dinucleotide (NAD). + ) into acetoacetate and reduced nicotinamide adenine dinucleotide (NADH), respectively. The enzyme cofactor NAD + and NADH promote the concerted enzymatic reaction disclosed herein. NADH can then undergo diaphorase-mediated reduction, and the electrons transferred during this process provide the basis for ketone detection at the working electrode. Thus, there is a 1:1 molar correspondence between the amount of electrons transferred to the working electrode and the amount of β-hydroxybutyrate converted, thereby providing the basis for detection and quantification of ketones based on the amount of current measured at the working electrode. The transfer of electrons resulting from NADH reduction to the working electrode can occur via an electron transfer agent, such as an osmium (Os) compound, as further described below. Albumin can be present as a stabilizer with this pair of concerted enzymes. According to certain embodiments, β-hydroxybutyrate dehydrogenase and diaphorase can be covalently attached to a polymer within the ketone-responsive active region of the analyte sensor. NAD + may or may not be covalently attached to the polymer, + If NAD is not covalently bound, it may be physically held within the ketone-responsive active region. +Within the ketone-responsive active region, while allowing sufficient inward diffusion to permit detection of the ketone. Suitable membrane polymers for coating the ketone-responsive active region are described further herein.

[0022] Other suitable chemical reactions for enzymatic detection of ketones are shown in Figures 2B and 2C. In both cases, there is a 1:1 molar correspondence between the amount of electrons transferred to the working electrode and the amount of β-hydroxybutyrate converted, thereby providing the basis for ketone detection.

[0023] As shown in Figure 2B, β-hydroxybutyrate dehydrogenase (HBDH) again converts β-hydroxybutyrate and NAD + Instead of the electron transfer to the working electrode being completed by diaphorase (see Figure 2A) and a transition metal electron transfer agent, the reduced form of NADH oxidase (NADH x (reduction)) reacts to produce the corresponding oxidized form (NADHO x (Oxidation)) is produced. Next, NADHO x (reduced) can be reformed by reaction with molecular oxygen to generate superoxide, which can be converted to hydrogen peroxide under the mediation of superoxide dismutase (SOD). Hydrogen peroxide can then be reduced at the working electrode to provide a signal that can be correlated to the amount of ketone originally present. According to various embodiments, SOD can be covalently attached to a polymer in the ketone-responsive active region. Similar to the enzyme system shown in FIG. 2A, β-hydroxybutyrate dehydrogenase and NADH oxidase can be covalently attached to a polymer in the ketone-responsive active region, and NAD may or may not be covalently attached to the polymer in the ketone-responsive active region. NAD + If NAD is not covalently bound, it will be physically held within the ketone-responsive active area, and the membrane polymer will not bind NAD within the ketone-responsive active area. + Promote retention of

[0024] As shown in Figure 2C, a further enzymatic ketone detection chemistry utilizes β-hydroxybutyrate dehydrogenase (HBDH) to convert β-hydroxybutyrate and NAD + to acetoacetate and NADH, respectively. The electron transfer cycle in this case is completed by oxidation of poly-1,10-phenanthroline-5,6-dione at the working electrode to reform NAD. Poly-1,10-phenanthroline-5,6-dione may or may not be covalently attached to the polymer in the ketone-responsive active region. Similar to the enzyme system shown in Figure 2A, β-hydroxybutyrate dehydrogenase may be covalently attached to the polymer in the ketone-responsive active region, and NAD may or may not be covalently attached to the polymer in the ketone-responsive active region. The inclusion of albumin in the active region may surprisingly improve the stability of the response. A suitable membrane polymer can be used to inhibit the oxidation of NAD in the ketone-responsive active region. + This may promote retention of

[0025] The glucose-responsive active region of the analyte sensors disclosed herein can be physically adsorbed to the working electrode surface and can include a glucose-responsive enzyme, such as glucose oxidase or glucose dehydrogenase. According to various embodiments, the glucose-responsive active region can include a polymer covalently bonded to the glucose-responsive enzyme. Polymers suitable for inclusion in the active region are described below.

[0026] Analyte sensors disclosed herein may feature different types of active regions (i.e., glucose-responsive active regions and ketone-responsive active regions) provided on a single working electrode or on two or more separate working electrodes. Single working electrode sensor configurations may use two-electrode or three-electrode detection motifs, as in accordance with various embodiments of the present disclosure and as further described herein. Sensor configurations featuring a single working electrode are described below with reference to Figures 3A-3C. Each of these sensor configurations may suitably incorporate glucose-responsive active regions and ketone-responsive active regions, as in accordance with various embodiments of the present disclosure. Thereafter, sensor configurations featuring multiple working electrodes are described with reference to Figures 4 and 5A-5D. When multiple working electrodes are present, the ketone-responsive active region may be disposed on a first working electrode and the glucose-responsive active region may be disposed on a second working electrode. Sensor configurations using multiple working electrodes may be particularly advantageous for incorporating both glucose-responsive and ketone-responsive active regions according to the present disclosure, since mass transport limiting membranes having different compositions and / or different permeability values ​​can be more easily formed in the manufacturing process when the active regions are separated and / or spaced apart in this manner. A particular sensor configuration featuring multiple working electrodes arranged to facilitate deposition, particularly by dip coating, of mass transport limiting membranes having different compositions on each working electrode is shown in Figures 5A-5D. Suitable techniques for depositing the mass transport limiting membranes disclosed herein include, for example, spray coating, painting, inkjet printing, stenciling, roller coating, dip coating, and the like, and any combination thereof.

[0027] When a single working electrode is present in the analyte sensor, a three-electrode sensor configuration may include a working electrode, a counter electrode, and a reference electrode. A related two-electrode sensor configuration may include a working electrode and a second electrode, which may function as both the counter electrode and the reference electrode (i.e., counter / reference electrode). In both two-electrode and three-electrode sensor configurations, both the glucose-responsive active area and the ketone-responsive active area may be disposed on a single working electrode. In some embodiments, the various electrodes may be at least partially stacked (layered) on one another and / or laterally spaced apart from one another on the sensor tail. Suitable sensor configurations may be substantially flat or substantially cylindrical in shape, with the glucose-responsive active area and the ketone-responsive active area being laterally spaced apart on the working electrode. In all sensor configurations disclosed herein, the various electrodes may be electrically insulated from one another by a dielectric material or similar insulator.

[0028] Analyte sensors featuring multiple working electrodes may similarly include at least one additional electrode. If one additional electrode is present, the one additional electrode may function as a counter / reference electrode for each of the multiple working electrodes. If two additional electrodes are present, one of the additional electrodes may function as a counter electrode for each of the multiple working electrodes, and the other of the additional electrodes may function as a reference electrode for each of the multiple working electrodes.

[0029] Analyte sensor configurations with a single working electrode are now described in more detail. FIG. 3A shows a cross-sectional view of an exemplary two-electrode analyte sensor configuration with a single working electrode that is compatible for use in some embodiments of the present disclosure herein. As shown, the analyte sensor 200 includes a substrate 212 disposed between a working electrode 214 and a counter / reference electrode 216. Alternatively, the working electrode 214 and the counter / reference electrode 216 can be disposed on the same side of the substrate 212 with a dielectric material interposed therebetween (configuration not shown). The active areas 218a and 218b (i.e., the glucose-responsive active area and the ketone-responsive active area) are laterally spaced apart from one another on the surface of the working electrode 210. In various sensor configurations shown herein, the active areas 218a and 218b can include multiple spots or a single spot configured for detection of each analyte. The analyte sensor 200 may be operable to assay glucose and ketones by any of the following electrochemical detection techniques: coulometric, amperometric, voltammetric, or potentiometric.

[0030] 3A, according to some embodiments, the membrane 220 covers at least the active areas 218a, 218b, and can optionally cover part or all of the working electrode 214 and / or counter / reference electrode 216, or the entire analyte sensor 200. One or both sides of the analyte sensor 200 may be covered with the membrane 220. The membrane 220 may include one or more polymeric membrane materials (membrane polymers) having suitable capabilities for restricting the flow of analytes to the active areas 218a and 218b. Although not necessarily apparent in FIG. 3A, the composition of the membrane 220 may vary in the active areas 218a and 218b to differentially regulate the analyte flux at each location, as further described herein. For example, the membrane 220 may be sprayed and / or printed on the active areas 218a and 218b such that the composition of the membrane 220 is different at each location. In another alternative, the membrane 220 may be deposited by dip coating starting from end A of the analyte sensor 200. Specifically, end A of the analyte sensor 200 can be dipped into a first coating formulation to cover the active area 218a. After the first coating formulation is partially cured on the active area 218a, end A of the analyte sensor 200 can be dipped into a second coating formulation to apply the second coating formulation to both active areas 218a and 218b. Thus, the membrane 220 can be continuous and feature a bilayer in the active area 218a and can be homogenous in the active area 218b.

[0031] 3B and 3C show cross-sectional views of an exemplary three-electrode sensor configuration with a single working electrode suitable for use in some embodiments of the present disclosure herein. A three-electrode sensor configuration featuring a single working electrode may be similar to that shown for the analyte sensor 200 of FIG. 3A, except that an additional electrode 217 is included in the analyte sensors 201 and 202 (FIGS. 3B and 3C). With the additional electrode 217, the electrode 216 can then function as either a counter electrode or a reference electrode, and the additional electrode 217 can perform other electrode functions not otherwise described. The working electrode 214 still performs its original function in either case. The additional electrode 217 can be disposed on either the working electrode 210 or the electrode 216, with a dielectric separation layer between each. For example, as shown in FIG. 3B, the electrodes 210, 216, and 217 are disposed on the same side of the substrate 212 and are electrically insulated from each other by the dielectric layers 219a, 219b, and 219c therebetween. Alternatively, as shown in FIG. 3C, at least one of the electrodes 210, 216, and 217 may be disposed on opposite sides of the substrate 212. Thus, in some embodiments, the electrode 210 (working electrode) and the electrode 216 (counter electrode) may be disposed on opposite sides of the substrate 212, and the electrode 217 (reference electrode) is disposed on one of the electrodes 210 or 216 with a dielectric material spaced therebetween. A reference material layer 230 (e.g., Ag / AgCl) may be present on the electrode 217, and the location of the reference material layer 230 is not limited to that shown in FIG. 3B and 3C. Similar to the analyte sensor 200 shown in FIG. 3A, the active areas 218a and 218b of the analyte sensors 201 and 202 are disposed laterally spaced apart from each other on the working electrode 210 in the sensor configuration of FIG. 3B and 3C. Similar to analyte sensor 200, analyte sensors 201, 202 may be operable to assay glucose and ketones by any of the following electrochemical detection techniques: coulometric, amperometric, voltammetric, or potentiometric.

[0032] Also, similar to analyte sensor 200, membrane 220 can also cover active areas 218a and 218b, as well as other sensor components, in analyte sensors 201 and 202. In some embodiments, additional electrode 217 can be covered with membrane 220. Although FIGS. 3B and 3C show all of electrodes 214, 216, and 217 covered with membrane 220, it should be appreciated that in some embodiments, only working electrode 210 or one of active areas 218a, 218b can be covered. Although not evident in FIGS. 3B and 3C, the thickness of membrane 220 can be the same or different at various locations, such as thickness variations at active areas 218a and 218b. Similarly, membrane 220 can also be compositionally varied at active areas 218a and 218b to differentially regulate analyte flux at each location. For example, dip coating from end A of analyte sensors 201 and 202 can be used to deposit a continuous membrane featuring a bilayer membrane portion in active area 218a and a uniform membrane portion in active area 218b, as described in more detail above with respect to Figure 3A. As in the two-electrode analyte sensor configuration (Figure 3A), one or both sides of analyte sensors 201 and 202 may be covered with membrane 220 in the sensor configurations of Figures 2B and 2C, or the entire analyte sensors 201 and 202 may be covered. Thus, the three-electrode sensor configurations shown in Figures 3B and 3C are illustrative and non-limiting of the present disclosure, and it should be understood that alternative electrode and / or layer configurations are within the scope of the present disclosure.

[0033] Sensor configurations having multiple working electrodes, more particularly two working electrodes, will now be described in further detail with reference to Figures 4 and 5A-5D. While the following description is directed primarily to sensor configurations having two working electrodes, it should be understood that more than two working electrodes may be incorporated throughout the disclosure herein. Additional working electrodes can be used to provide additional detection capabilities to the analyte sensor beyond just glucose and ketone detection.

[0034] FIG. 4 illustrates a cross-sectional view of an exemplary analyte sensor configuration having two working electrodes, a reference electrode and a counter electrode, suitable for use in some embodiments of the present disclosure herein. As shown in FIG. 4, the analyte sensor 300 has working electrodes 304 and 306 disposed on opposite sides of a substrate 302. An active area 310a is disposed on the surface of the working electrode 304, and an active area 310b is disposed on the surface of the working electrode 306. According to various embodiments of the present disclosure, the active areas 310a and 310b can be glucose-responsive and ketone-responsive. The counter electrode 320 is electrically insulated from the working electrode 304 by a dielectric layer 322, and the reference electrode 321 is electrically insulated from the working electrode 306 by a dielectric layer 323. Outer dielectric layers 330 and 332 are disposed on the reference electrode 321 and the counter electrode 320, respectively. The membrane 340, according to various embodiments, has a first membrane portion 340a and a second membrane portion 340b separately covering at least the active areas 310a and 310b, respectively, and optionally also covering other components of the analyte sensor 300 or the entire analyte sensor 300 with the first membrane portion 340a and / or the second membrane portion 340b. Again, the membrane 340 may be continuous, but may be compositionally different in the first membrane portion 340a and the second membrane portion 340b (i.e., on the active areas 310a and 310b) to provide different permeability values ​​for differentially adjusting the analyte flux at each location. For example, different membrane formulations may be sprayed and / or printed on opposing sides of the analyte sensor 300. Dip-coating techniques may also be suitable for depositing at least a portion of the bilayer membrane, particularly on one of the active areas 310a and 310b. Thus, according to certain embodiments of the present disclosure, one of the first membrane portion 340a and the second membrane portion 340b can comprise a bilayer membrane, and the other of the first membrane portion 340a and the second membrane portion 340b can comprise a single membrane polymer. Similar to analyte sensors 200, 201, 202, analyte sensor 300 can be operable to assay glucose and ketones by any of the following electrochemical detection techniques: coulometric, amperometric, voltammetric, or potentiometric.

[0035] Alternative sensor configurations having multiple working electrodes and different from that shown in Figure 4 may feature counter / reference electrodes instead of separate counter and reference electrodes 320, 321, and / or feature layer and / or membrane arrangements different from those explicitly shown. For example, the arrangement of counter electrode 320 and reference electrode 321 may be reversed from that shown in Figure 4. Additionally, working electrodes 304 and 306 do not necessarily need to be on opposing sides of substrate 302 as shown in Figure 4.

[0036] Although suitable sensor configurations may feature electrodes that are substantially planar in nature, it should be understood that sensor configurations featuring non-planar electrodes are advantageous and particularly suitable for use with the present disclosure. In particular, substantially cylindrical electrodes arranged concentrically with respect to one another may facilitate deposition of a mass transport limiting film, as described below. Figures 5A-5D show perspective views of analyte sensors featuring substantially cylindrical electrodes arranged concentrically with respect to one another. Although Figures 5A-5D show sensor configurations featuring two working electrodes, it should be understood that similar sensor configurations having either one working electrode or three or more working electrodes are possible with application of the present disclosure.

[0037] 5A shows a perspective view of an exemplary sensor configuration in which multiple electrodes are substantially cylindrical and concentrically disposed around one another around a central substrate. As shown, the analyte sensor 400 has a central substrate 402 on which all of the electrodes and dielectric layers are concentrically disposed around one another. In particular, a working electrode 410 is disposed on a surface of the central substrate 402, and a dielectric layer 412 is disposed on a portion of the working electrode 410 distal to the sensor tip 404. A working electrode 420 is disposed on the dielectric layer 412, and a dielectric layer 422 is disposed on a portion of the working electrode 420 distal to the sensor tip 404. A counter electrode 430 is disposed on the dielectric layer 422, and a dielectric layer 432 is disposed on a portion of the counter electrode 430 distal to the sensor tip 404. A reference electrode 440 is disposed on the dielectric layer 432, and a dielectric layer 442 is disposed on a portion of the reference electrode 440 distal to the sensor tip 404. Thus, the exposed surfaces of working electrode 410, working electrode 420, counter electrode 430, and reference electrode 440 are spaced apart from one another along the longitudinal axis B of analyte sensor 400. Spacing of working electrodes 410 and 420 along the longitudinal axis can also be achieved in substantially planar sensor configurations such as those provided above.

[0038] 5A, active areas 414a and 414b are disposed on the exposed surfaces of working electrodes 410 and 420, respectively, thereby allowing contact with a fluid to occur for glucose and / or ketone detection to occur. Although active areas 414a and 414b are depicted as three separate regions in FIG. 5A, it should be understood that in alternative sensor configurations there may be fewer or more than three regions. Each of active areas 414a and 414b may also be a continuous layer disposed as a ring on the exposed surfaces of working electrodes 410 and 420, respectively.

[0039] Similar to the sensor configurations described above, at least the working electrodes 410 and 420 and the active areas 414a and 414b thereon are coated with a membrane in the sensor configuration of FIG. 5A. Although a membrane featuring a single composition may coat the active areas 414a and 414b, the membrane composition may vary in composition at each location to provide different permeability values, thereby leveling out the sensor response for each analyte. In the sensor configuration shown in FIG. 5A, a membrane portion 450 having a first composition coats the working electrode 410 and the active area 414a, along with an optional coating of the dielectric layer 412, and a membrane portion 451 having a second composition different from the first composition coats the working electrode 420 and the active area 414b, and optionally the dielectric layer 412 and / or the dielectric layer 422. Although not shown in FIG. 5A, the counter electrode 430, the reference electrode 440, and the dielectric layers 432 and 442 may also be coated with a membrane 451.

[0040] FIG. 5B illustrates an alternative sensor configuration to that shown in FIG. 5A. In this configuration, all components on the sensor tail are membrane coated. In the sensor configuration shown in FIG. 5B, the sensor 401 includes the working electrode 410, the active area 414a, and the dielectric layer 412, each of which is coated with a first portion 452a of the membrane 452. The first portion 452a includes two membrane layers, thereby defining a bilayer membrane. The second portion 452b of the membrane 452 coats the working electrode 420, the active area 414b, and the remainder of the sensor tail (i.e., the counter electrode 430, the reference electrode 440, and the dielectric layers 422, 432, 442) with a single membrane polymer. Although shown as having two portions 452a and 452b, it should be understood that there may be additional portions. Additionally, the first portion 452a may be a bilayer membrane as shown, or may be a homogenous mixture of multiple membrane polymers. According to various embodiments of the present disclosure, a sensor configuration having a first portion 452a as a bilayer membrane can feature an active area 414a that is ketone responsive and an active area 414b that is glucose responsive. Further details regarding suitable membrane polymers and techniques for deposition of the first and second portions 452a, 452b of the membrane 452 at each location are provided below.

[0041] It should be further understood that the arrangement of the various electrodes in Figures 5A and 5B may differ from that explicitly shown. For example, the positions of the counter electrode 430 and the reference electrode 440 may be reversed from the configuration shown in Figures 5A and 5B. Similarly, the positions of the working electrodes 410 and 420 are not limited to those explicitly shown in Figures 5A and 5B. Figure 5C illustrates an alternative sensor configuration to that shown in Figure 5B, where the sensor 405 has the counter electrode 430 and the reference electrode 440 located more proximally from the sensor tip 404 and the working electrodes 410 and 420 located more distally of the sensor tip 404. A sensor configuration in which the working electrodes 410, 420 are located more distally relative to the sensor tip 404 may be advantageous as it provides a larger surface area for the deposition of the active regions 414a, 414b (five separate detection regions exemplarily shown in Figure 5C), potentially facilitating enhanced signal strength. The positions of the bilayer membrane defined by first portion 452 a and the homogeneous membrane defined by second portion 452 b are similarly adjusted to accommodate changes in the position of working electrodes 410 and 420 .

[0042] While Figures 5A-5C each show a sensor configuration supported on a central substrate 402, it should be understood that alternative sensor configurations may be supported by electrodes instead and may not have a central substrate 402. In particular, the innermost concentric electrode may be utilized to support the other electrodes and dielectric layers. Figure 5D shows an alternative sensor configuration to that shown in Figure 5C, where sensor 406 does not include a central substrate 402, and counter electrode 430 is the innermost concentric electrode and is used to sequentially position reference electrode 440, working electrodes 410, 420, and dielectric layers 432, 442, 412, 422 thereon. In light of the disclosure herein, it should again be understood that other electrode and dielectric layer configurations may be used in sensor configurations lacking a central substrate 402. Thus, the sensor configuration shown in Figure 5D should be considered exemplary and non-limiting in nature.

[0043] Thus, some embodiments of the analyte sensor disclosed herein may include at least a working electrode, a glucose-responsive active region including a glucose-responsive enzyme disposed on the surface of the working electrode, and a sensor tail including a ketone-responsive active region disposed on the surface of the working electrode away from the glucose-responsive active region. The ketone-responsive active region includes an enzyme system including at least two enzymes that can act in concert to facilitate detection of ketones. Each active region has a constant redox potential, and the redox potential of the glucose-responsive active region is sufficiently separated from the redox potential of the ketone-responsive active region to allow independent generation of a signal from either the glucose-responsive active region or the ketone-responsive active region.

[0044] When glucose-responsive active areas and ketone-responsive active areas are disposed on a single working electrode in this manner, one of the active areas can be configured to be interrogated separately to facilitate detection of each analyte, as described below, i.e., either the glucose-responsive active area or the ketone-responsive active area can generate a signal independently of the other active area.

[0045] Some or other embodiments of the analyte sensors disclosed herein may feature glucose-responsive active regions and ketone-responsive active regions on different working electrode surfaces. Such analyte sensors may have a sensor tail with at least a first working electrode and a second working electrode, the sensor tail having a ketone-responsive active region disposed on the surface of the first working electrode, a glucose-responsive active region including a glucose-responsive enzyme disposed on the surface of the second working electrode, and a membrane, a first portion covering the ketone-responsive active region and a second portion covering the glucose-responsive active region, the first portion and the second portion having different compositions.

[0046] In certain embodiments, the first portion is multi-component and comprises at least a first membrane polymer and a second membrane polymer that are different from each other, and the second portion is homogenous and comprises one of the first membrane polymer and the second membrane polymer.

[0047] According to various embodiments of the present disclosure, an electron transfer agent may be present in the glucose-responsive active area and the ketone-responsive active area in any of the exemplary sensor configurations disclosed herein. A suitable electron transfer agent may facilitate the transport of electrons to the adjacent working electrode after any analyte undergoes an enzymatic redox reaction in the corresponding active area, thereby generating a current indicative of the presence of that particular analyte. The amount of current generated is proportional to the amount of analyte present. Depending on the sensor configuration used, the electron transfer agents in the glucose-responsive active area and the ketone-responsive active area may be the same or different. For example, if the glucose-responsive active area and the ketone-responsive active area are disposed on the same working electrode, the electron transfer agents in each active area may be different (e.g., chemically different so that the electron transfer agents exhibit different redox potentials). If multiple working electrodes are present, the electron transfer agents in each active area may be the same or different, since each working electrode may be interrogated separately.

[0048] According to various embodiments of the present disclosure, suitable electron transfer agents include electroreducible and electrooxidizable ions, complexes, or molecules (e.g., quinones) that have redox potentials several hundred millivolts higher or lower than the redox potential of a standard calomel electrode (SCE). According to some embodiments, suitable electron transfer agents may include low potential osmium complexes, such as those described in U.S. Patent Nos. 6,134,461 and 6,605,200, which are incorporated herein by reference in their entireties. Additional examples of suitable electron transfer agents include those described in U.S. Patent Nos. 6,736,957, 7,501,053, and 7,754,093, the disclosures of each of which are incorporated herein by reference in their entireties. Other suitable electron transfer agents include metal compounds or complexes of ruthenium, osmium, iron (e.g., polyvinylferrocene or hexacyanoferrate), or cobalt, including, for example, metallocene compounds thereof. Suitable ligands for metal complexes may also include bidentate or higher dentate ligands, such as, for example, bipyridine, biimidazole, phenanthroline, or pyridyl (imidazole). Other suitable bidentate ligands may include, for example, amino acids, oxalic acid, acetylacetone, diaminoalkanes, or o-diaminoarenes. Any combination of monodentate, bidentate, tridentate, tetradentate, or higher dentate ligands may be present in the metal complex to achieve a complete coordination sphere.

[0049] Active regions suitable for detecting glucose and ketones may also include polymers to which electron transfer agents are covalently attached. Any of the electron transfer agents disclosed herein may include appropriate functionality to facilitate covalent attachment to the polymer in the active region. Suitable examples of polymer-bound electron transfer agents include those described in U.S. Pat. Nos. 8,444,834, 8,268,143, and 6,605,201, the disclosures of which are incorporated herein by reference in their entirety. Polymers suitable for inclusion in the active region may include, but are not limited to, polyvinylpyridine (e.g., poly(4-vinylpyridine)), polyvinylimidazole (e.g., poly(1-vinylimidazole)), or any copolymers thereof. Exemplary copolymers that may be suitable for inclusion in the active region include those that include monomer units such as, for example, styrene, acrylamide, methacrylamide, or acrylonitrile. The polymers in each active region may be the same or different.

[0050] In certain embodiments of the present disclosure, the mass transport limiting membrane covering each active area may include at least a crosslinked polyvinylpyridine homopolymer or copolymer. The composition of the mass transport limiting membrane may be the same or different when it covers each active area. In certain embodiments, the portion of the mass transport limiting membrane covering the glucose-responsive active area may be single component (comprising a single membrane polymer) and the portion of the mass transport limiting membrane covering the ketone-responsive active area may be multi-component (comprising two or more different membrane polymers, one of which is a polyvinylpyridine homopolymer or copolymer). Multi-component membranes may exist as bilayer membranes or as homogeneous mixtures of two or more membrane polymers. A homogeneous mixture may be deposited by combining two or more membrane polymers in a solution and then depositing the solution on the working electrode. In an even more specific embodiment of the present disclosure, the glucose-responsive active region can be coated with a membrane comprising a polyvinylpyridine-co-styrene copolymer, and the ketone-responsive active region can be coated with a multi-component membrane of the copolymers comprising polyvinylpyridine and polyvinylpyridine-co-styrene, either as a bilayer membrane or a homogeneous mixture.

[0051] The method of covalent bonding between the electron transfer agent and the polymer comprising each active region is not considered to be particularly limited. The covalent bonding of the electron transfer agent to the polymer can occur by polymerizing a monomer unit having a covalently bonded electron transfer agent, or the electron transfer agent can be reacted separately with the polymer after the polymer has already been synthesized. According to some embodiments, a bifunctional spacer can covalently bond the electron transfer agent to the polymer in the active region, with a first functional group reactive with the polymer (e.g., a functional group capable of quaternizing the pyridine nitrogen atom or the imidazole nitrogen atom) and a second functional group (e.g., a functional group that reacts with a ligand that coordinates a metal ion) capable of reacting with the electron transfer agent.

[0052] Similarly, according to some or various other embodiments of the present disclosure, one or more enzymes in an active area may be covalently attached to a polymer. When an enzyme system comprising multiple enzymes is present in a given active area, in some embodiments, all of the multiple enzymes may be covalently attached to the polymer, and in other embodiments, only a portion of the multiple enzymes may be covalently attached to the polymer. For example, one or more enzymes comprising the enzyme system may be covalently attached to the polymer, and at least one enzyme may be non-covalently attached to the polymer such that the non-covalently attached enzyme is physically incorporated within the polymer. According to more specific embodiments, the covalent attachment of the enzyme to the polymer in a given active area may occur via a crosslinker in which a suitable crosslinker is introduced. Suitable crosslinkers for reaction with free amino groups in an enzyme (e.g., with free side chain amines in lysine) include, for example, polyethylene glycol diglycidyl ether (PEGDGE) or other polyepoxides, cyanuric chloride, N-hydroxysuccinimide, imidoesters, epichlorohydrin, or derivatized versions thereof. Suitable crosslinkers for reaction with free carboxylic acid groups in an enzyme may include, for example, carbodiimides. Cross-linking of the enzyme to the polymer is generally intermolecular, but in some embodiments can be intramolecular.

[0053] The electron transfer agent and / or enzyme can be associated with the polymer in the active area by means other than covalent bonding. In some embodiments, the electron transfer agent and / or enzyme can be ionically or coordinatively associated with the polymer. For example, a charged polymer can be ionically associated with an oppositely charged electron transfer agent or enzyme. In yet other embodiments, the electron transfer agent and / or enzyme can be physically entrapped within the polymer without being bound to the polymer. The physically entrapped electron transfer agent and / or enzyme can still adequately interact with the fluid to facilitate detection of the analyte without being substantially leached from the active area.

[0054] In certain embodiments, a glucose-responsive enzyme of the glucose-responsive active region can be covalently attached to a polymer of the glucose-responsive active region along with an electron transfer agent that is also covalently attached to the polymer.

[0055] In other particular embodiments, at least a portion of the enzymes of the enzyme system in the ketone-responsive active region may be covalently attached to the polymer of the ketone-responsive active region, along with an electron transfer agent that is covalently attached to the polymer. One suitable enzyme system that may be suitable for facilitating the detection of ketones is β-hydroxybutyrate dehydrogenase (NADH), nicotinamide adenine dinucleotide (NADH), or ketone dehydrogenase (KD). + ), and diaphorase (see FIG. 2A). In certain embodiments of the present disclosure, β-hydroxybutyrate dehydrogenase and diaphorase may be covalently attached to a polymer in the ketone-responsive active region, and NAD + The polymer in the ketone-responsive active region can be non-covalently associated with the polymer. + The membrane polymer that coats the ketone-responsive active region can be selected to limit the outward diffusion of NAD. +to facilitate reasonable sensor lifetimes (days to weeks), while allowing sufficient inward ketone diffusion to facilitate detection. In yet another embodiment, components of the enzyme system described above may be covalently bound or non-covalently engaged with a polymer in a ketone-responsive active region, as described above, along with an electron transfer agent that is covalently bound to the polymer.

[0056] The glucose-responsive and ketone-responsive active regions of the analyte sensors disclosed herein consist of one or more discrete regions (e.g., from 1 to about 10 regions, or more regions) and are approximately 0.01 mm in size. 2 ~about 1mm 2 where larger or smaller individual regions within the active area are also contemplated herein. An active area defined as a continuous band around a cylindrical electrode is also possible in the disclosure herein.

[0057] In more specific embodiments, the analyte sensors of the present invention may include a sensor tail configured for insertion into tissue. Suitable tissues are not believed to be particularly limited and are described in more detail above. Similarly, considerations for deploying the sensor tail at a particular location within tissue are also described above.

[0058] In embodiments in which the glucose-responsive active area and the ketone-responsive active area are disposed on a single working electrode, the redox potential associated with the glucose-responsive active area may be separated from the redox potential of the ketone-responsive active area by at least about 100 mV, or at least about 150 mV, or at least about 200 mV. The upper limit of the separation between the redox potentials is determined by the in vivo operating electrochemical window. By sufficiently separating the redox potentials of the two active areas from each other, an electrochemical reaction occurs within one of the two active areas (i.e., within the glucose-responsive active area or the ketone-responsive active area) without substantially inducing an electrochemical reaction within the other active area. Thus, a signal from one of the glucose-responsive active area or the ketone-responsive active area may be independently generated at a potential equal to or greater than the corresponding redox potential (lower redox potential) but lower than the redox potential (higher redox potential) of the other glucose-responsive active area and ketone-responsive active area. In contrast, above the redox potential of other active regions not previously investigated (higher redox potentials), electrochemical reactions can occur in both the glucose-responsive active region and the ketone-responsive active region. Thus, the signal obtained above the higher redox potential may include signal contributions from both the glucose-responsive active region and the ketone-responsive active region, and the signal observed is a composite signal. The signal contribution from one active region above the redox potential (either the glucose-responsive active region or the ketone-responsive active region) can then be determined by subtracting from the composite signal the signal obtained only from either the glucose-responsive active region or the ketone-responsive active region above the corresponding redox potential.

[0059] In more detailed embodiments, the glucose-responsive active region and the ketone-responsive active region can include different electron transfer agents to provide redox potentials that are sufficiently separated in magnitude from one another when the active regions are located on the same working electrode. More specifically, the glucose-responsive active region can include a first electron transfer agent and the ketone-responsive active region can include a second electron transfer agent, where the first and second electron transfer agents are different. According to various embodiments of the present disclosure, the metal center and / or ligands present in a given electron transfer agent can be varied to provide sufficient separation of redox potentials in the two active regions.

[0060] Ideally, the glucose-responsive active region and the ketone-responsive active region disposed on a single working electrode can be configured to rapidly achieve a steady-state current upon operation of the analyte sensor at a given potential. Rapid achievement of a steady-state current can be facilitated by selecting an electron transfer agent for each active region that rapidly changes its oxidation state upon exposure to a potential equal to or greater than its redox potential. Making the active regions as thin as possible can also facilitate rapid achievement of a steady-state current. For example, suitable thicknesses for the glucose-responsive active region and the ketone-responsive active region can range from about 0.1 microns to about 10 microns. In some or other embodiments, combining conductive materials, such as, for example, carbon nanotubes, graphene, or metal nanoparticles, within one or more active regions can facilitate rapid achievement of a steady-state current. Suitable amounts of conductive particles can range from about 0.1% to about 50% by weight, or from about 1% to about 50% by weight, or from about 0.1% to about 10% by weight, or from about 1% to about 10% by weight of the active region. Stabilizers can also be used to promote stability of the response.

[0061] It should also be understood that the sensitivity (output current) of the analyte sensor to each analyte can be varied by varying the coverage (area or size) of the active regions, the area ratio of the active regions to each other, the identity, thickness, and / or composition of the mass transport limiting membrane covering the active regions. Variations in these parameters can be readily implemented by one of ordinary skill in the art once given the benefit of the disclosure herein.

[0062] A detection method for assaying glucose and ketones using an analyte sensor featuring a glucose-responsive active area and a ketone-responsive active area on a single working electrode may include: exposing the analyte sensor to a fluid containing at least one of glucose and ketones. The analyte sensor has at least a working electrode, particularly a single working electrode, and a sensor tail that is disposed on the surface of the working electrode and includes at least a glucose-responsive active area and a ketone-responsive active area spaced apart from the glucose-responsive active area. The glucose-responsive active area includes a glucose-responsive enzyme and a polymer, and the ketone-responsive active area includes an enzyme system that includes two or more enzymes that can act in concert to facilitate detection of ketones. Each active area has an oxidation-reduction potential, and the oxidation-reduction potential of a first active area (e.g., either the glucose-responsive active area or the ketone-responsive active area) is sufficiently separated from the oxidation-reduction potential of the other of the glucose-responsive active area or the ketone-responsive active area to allow generation of a signal from the first active area independent of generation of a signal from the other active area. The method further includes acquiring a first signal at or above the lower of the first and second redox potentials but below the higher of the first and second redox potentials, whereby the signal is proportional to the concentration of one of glucose or ketone in the fluid; acquiring a second signal at or above the higher of the first and second redox potentials, whereby the second signal is a composite signal including a signal contribution from the glucose-responsive active region and a signal contribution from the ketone-responsive active region; and subtracting the first signal from the second signal to obtain a difference signal, where the difference signal is proportional to the concentration of one of glucose and ketone.

[0063] In more detailed embodiments, the redox potential associated with the first active region may be separated from the redox potential of the second active region by at least about 100 mV, or at least about 150 mV, or at least about 200 mV to provide sufficient separation for independent generation of a signal from the first active region. In particular, the redox potentials of the first and second active regions may be separated by about 100 mV to about 500 mV, or about 100 mV to about 400 mV, or about 100 mV to about 300 mV.

[0064] In some embodiments, the signal associated with each active region can be correlated to the corresponding glucose or ketone concentration by referencing a lookup table or calibration curve for each analyte. The lookup table for each analyte can be created by analyzing multiple samples with known analyte concentrations and recording the sensor response at each concentration of each analyte. Similarly, a calibration curve for each analyte can be determined by plotting the analyte sensor response for each analyte as a function of concentration and determining an appropriate calibration function (e.g., by regression, particularly linear regression) over the calibration range.

[0065] The processor may determine which sensor response value in the lookup table is closest to that measured for the sample with unknown analyte concentration and report the analyte concentration accordingly. In some or other embodiments, if the sensor response value of the sample with unknown analyte concentration is between the values ​​recorded in the lookup table, the processor may interpolate between the two lookup table values ​​to estimate the analyte concentration. Interpolation may assume a linear concentration variation between the two values ​​reported in the lookup table. Interpolation may be used when the sensor response is sufficiently different from a particular value in the lookup table (e.g., a variation of about 10% or more).

[0066] Similarly, according to some or various other embodiments, the processor can input the sensor response values ​​of samples having unknown analyte concentrations into a corresponding calibration function, and the processor can then report the analyte concentrations accordingly.

[0067] A detection method for assaying glucose and ketones using an analyte sensor featuring glucose-responsive active areas and ketone-responsive active areas on separate working electrodes may include: exposing the analyte sensor to a fluid containing at least one of glucose and ketones. The analyte sensor may have a sensor tail with at least a first working electrode and a second working electrode, the sensor tail having a ketone-responsive active area disposed on a surface of the first working electrode, a glucose-responsive active area disposed on a surface of the second working electrode, and a membrane, the first portion of which covers the ketone-responsive active area and the second portion of which covers the glucose-responsive active area. The glucose-responsive active area includes a glucose-responsive enzyme and the ketone-responsive active area has an enzyme system including at least two enzymes that can act in concert to facilitate detection of ketones.

[0068] In certain embodiments, the first portion is multicomponent and includes at least a first membrane polymer and a second membrane polymer that are distinct from one another, and the second portion is homogenous and includes one of the first membrane polymer and the second membrane polymer. Thus, the membrane covering the glucose-responsive active region is compositionally distinct from the multicomponent membrane covering the ketone-responsive active region.

[0069] The method further comprises applying a constant potential to the first working electrode and the second working electrode, acquiring a first signal at or above the redox potential of the glucose-responsive active region, where the first signal is proportional to the concentration of glucose in the fluid, acquiring a second signal at or above the redox potential of the ketone-responsive active region, where the second signal is proportional to the concentration of ketone in the fluid, and correlating the first signal to the concentration of glucose and the second signal to the concentration of ketone in the fluid.

[0070] The first portion of the membrane may include a mixture of membrane polymers in some embodiments of the present disclosure, or may include a bilayer membrane or other membrane structure having at least two membrane layers in other embodiments of the present disclosure. When the first portion of the membrane includes a bilayer membrane, the bilayer membrane may have a first membrane polymer disposed on the ketone-responsive active area, and a second membrane polymer disposed on the first membrane polymer. The homogeneous membrane covering the glucose-responsive active area may consist of a second membrane polymer. That is, the first membrane polymer may be disposed directly on the ketone-responsive active area, and the second membrane polymer may be disposed on the first membrane polymer and the glucose-responsive active area. Thus, the first portion of the membrane may be thicker than the second portion of the membrane. As described above, this type of bilayer membrane and homogeneous membrane may be deposited by dip coating of a particular electrode configuration in some embodiments of the present disclosure. In certain embodiments of the present disclosure, a first portion of the membrane may include polyvinylpyridine (PVP) and polyvinylpyridine-co-styrene, and a second portion of the membrane may include polyvinylpyridine-co-styrene.

[0071] According to more specific embodiments, the first and second signals may be measured at different times. Thus, in such embodiments, a potential may be applied alternately to the first and second working electrodes. In other specific embodiments, the first and second signals may be measured simultaneously via the first and second channels, in which case a potential may be applied simultaneously to both electrodes. In either case, the signals associated with each active area may be correlated to glucose and ketone concentrations in a similar manner as described above using lookup tables or calibration functions.

[0072] Embodiments disclosed herein include the following. A. An analyte sensor responsive to glucose and ketones. The analyte sensor comprises a sensor tail including at least a working electrode, a glucose-responsive active region disposed on the working electrode and including a glucose-responsive enzyme, and a ketone-responsive active region disposed on the working electrode and spaced apart from the glucose-responsive active region, the ketone-responsive active region including an enzyme system including at least two enzymes that can act in concert to facilitate detection of ketones, where each active region has an oxidation-reduction potential, and where the oxidation-reduction potential of the glucose-responsive active region is sufficiently separated from the oxidation-reduction potential of the ketone-responsive active region to allow independent generation of a signal from one of the glucose-responsive active region or the ketone-responsive active region.

[0073] B. A method for analyzing glucose and ketones using a single analyte sensor, comprising exposing an analyte sensor to a fluid containing at least one of glucose and ketones, the analyte sensor having at least a working electrode, a sensor tail including a glucose-responsive active region disposed on the working electrode and having a first redox potential, and a ketone-responsive active region disposed on the working electrode and spaced from the glucose-responsive active region and having a second redox potential, wherein the glucose-responsive active region includes a glucose-responsive enzyme and the ketone-responsive active region includes an enzyme system including at least two enzymes capable of acting in concert to facilitate detection of ketones, the first redox potential and the second redox potential being correlated with one another to enable independent generation of a signal from one of the glucose-responsive active region or the ketone-responsive active region. The method includes exposing an analyte sensor to a substantially separated sample, acquiring a first signal at a redox potential equal to or greater than the lower of the first and second redox potentials but less than the higher of the first and second redox potentials, the first signal being proportional to a concentration of one of glucose or ketone in the fluid, acquiring a second signal at or greater than the higher of the first and second redox potentials, the second signal being a composite of the first signal contribution from the glucose-responsive active region and the first signal contribution from the ketone-responsive active region, and subtracting the first signal from the second signal to obtain a difference signal, the difference signal being proportional to the concentration of one of glucose or ketone in the fluid.

[0074] C. An analyte sensor responsive to glucose and ketones and having two working electrodes. The analyte sensor includes a sensor tail including at least a first working electrode and a second working electrode, a glucose-responsive active region disposed on the first working electrode and including a glucose-responsive enzyme, a ketone-responsive active region disposed on the second working electrode, the ketone-responsive active region including an enzyme system including at least two enzymes that can act in concert to facilitate detection of ketones, a first membrane covering the ketone-responsive active region, and a second membrane covering the glucose-responsive active region, where the first membrane and the second membrane have different permeability values.

[0075] D. A method for assaying glucose and ketones using a single analyte sensor having two working electrodes, the method comprising exposing an analyte sensor to a fluid containing at least one of glucose and ketones, the analyte sensor comprising a sensor tail having at least a first working electrode and a second working electrode, a glucose-responsive active area disposed on a surface of the first working electrode, a ketone-responsive active area disposed on a surface of the second working electrode, a first membrane covering the ketone-responsive active area, and a second membrane covering the glucose-responsive active area, where the first membrane and the second membrane have different permeability values, the glucose-responsive active area includes a glucose-responsive enzyme, and the ketone-responsive active area cooperates to facilitate detection of ketones. The method includes exposing an analyte sensor to an enzyme system comprising at least two enzymes capable of acting in concert with one another; applying a constant potential to the first and second working electrodes; acquiring a first signal at or above the redox potential of the glucose-responsive active region, the first signal being proportional to a concentration of glucose in the fluid; acquiring a second signal at or above the redox potential of the ketone-responsive active region, the second signal being proportional to a concentration of ketone in the fluid; and correlating the first signal to the concentration of glucose in the fluid and the second signal to the concentration of ketone in the fluid.

[0076] Each of embodiments A through D may have one or more of the following additional elements in any combination. Element 1: The sensor tail is configured for insertion into tissue.

[0077] Element 2: Wherein the redox potential of the glucose-responsive active region is at least about 100 mV away from the redox potential of the ketone-responsive active region. Element 3: wherein the glucose-responsive active region comprises a first electron transfer agent covalently bonded to a polymer in a first active region and the ketone-responsive active region comprises a second electron transfer agent covalently bonded to a polymer in a second active region, and the first and second electron transfer agents are different.

[0078] Element 4: Wherein the glucose-responsive enzyme is covalently bound to the polymer at a glucose-responsive active region and one or more of the at least two enzymes of the enzyme system is covalently bound to the polymer at a ketone-responsive active region.

[0079] Element 5: Wherein the analyte sensor further comprises a mass transport limiting membrane covering the glucose-responsive active area and the ketone-responsive active area. Element 6: The fluid is a biological fluid and the analyte sensor is exposed to the biological fluid in vivo.

[0080] Element 7: Here, the mass transport limiting membrane covers the glucose-responsive active region and the ketone-responsive active region. Element 8: Wherein the first membrane is a multicomponent membrane covering the ketone-responsive active area, the multicomponent membrane comprising at least a first membrane polymer and a second membrane polymer that are different from each other, and the second membrane is a homogenous membrane covering the glucose-responsive active area and differing in composition from the multicomponent membrane, the homogenous membrane comprising one of the first membrane polymer and the second membrane polymer.

[0081] Element 9: Wherein the multi-component membrane comprises a bilayer membrane. Element 10: A first membrane polymer is disposed directly on the ketone-responsive active area, and a second membrane polymer is disposed on the first membrane polymer to define a bilayer membrane, wherein the homogeneous membrane comprises the second membrane polymer.

[0082] Element 11: Here, the multi-component membrane comprises a mixture of a first membrane polymer and a second membrane polymer. Element 12: Wherein the multicomponent membrane comprises polyvinylpyridine and polyvinylpyridine-co-styrene and the homogeneous membrane comprises polyvinylpyridine-co-styrene.

[0083] Element 13: Wherein the glucose-responsive active region and the ketone-responsive active region each comprise an electron transfer agent covalently attached to a polymer in each of the glucose-responsive active region and the ketone-responsive active region.

[0084] Element 14: Wherein the first signal and the second signal are measured at different times. Element 15: Here, the first signal and the second signal are simultaneously acquired via the first channel and the second channel.

[0085] As non-limiting examples, exemplary combinations applicable to A and B include: 1 and 2; 1 and 3; 1 and 4; 1 and 5; 2 and 3; 2 and 4; 2 and 5; 3 and 4; 3 and 5; 4 and 5; 1 and 6; 2 and 6; 3 and 6; 4 and 6; 5 and 6.

[0086] As a further non-limiting example, exemplary combinations applicable to C and D include: 1 and 8; 4 and 8; 1 and 9; 4 and 9; 1 and 10; 4 and 10; 1 and 11; 4 and 11; 1 and 12; 4 and 12; 1 and 13; 4; 13; 1 and 14; 4 and 14; 1 and 15; 4 and 15; 4 and 9; 9 and 10; 4 and 11; 1 and 12; 4 and 13; 4 and 14; 1 and 15; 4 and 15; 4 and 9; 4, 9, 10; 4 and 11; 4 and 12; 4 and 13;4 and 14;4 and 15;8 and 9;8~10;8 and 11;8 and 12;8 and 13;8 and 14;8 and 15;9 and 10;9 and 11;9 and 12;9 and 13;9 and 14;9 and 15;11 and 12;11 and 13;11 and 14;11 and 15;12 and 13;12 and 14;12 and 15;13 and 14;13 and 15;14 and 15.

[0087] Additional embodiments disclosed herein include the following: A'. An analyte sensor responsive to glucose and ketones. The analyte sensor comprises a sensor tail including at least a first working electrode and a second working electrode, a ketone-responsive active region disposed on the surface of the first working electrode, the ketone-responsive active region including an enzyme system including at least two enzymes that can act in concert to facilitate detection of ketones, a glucose-responsive active region disposed on the surface of the second working electrode including a glucose-responsive enzyme, and a membrane having a first portion covering the ketone-responsive active region and a second portion covering the glucose-responsive active region, the first portion and the second portion having different compositions.

[0088] B'. A method of analyzing glucose and ketones using a single analyte sensor, the method comprising exposing an analyte sensor to a fluid containing at least one of glucose and ketones, the analyte sensor comprising a sensor tail having at least a first working electrode and a second working electrode, a ketone-responsive active area disposed on a surface of the first working electrode, a glucose-responsive active area disposed on a surface of the second working electrode, and a membrane having a first portion covering the ketone-responsive active area and a second portion covering the glucose-responsive active area, where the first portion and the second portion are of different compositions, the glucose-responsive active area includes a glucose-responsive enzyme, and the ketone-responsive active area facilitates detection of ketones. The method includes exposing an analyte sensor to an enzyme system comprising at least two enzymes capable of acting in concert to detect an analyte in the fluid; applying a constant potential to the first and second working electrodes; acquiring a first signal at or above the redox potential of the glucose-responsive active region, the first signal being proportional to a concentration of glucose in the fluid; acquiring a second signal at or above the redox potential of the ketone-responsive active region, the second signal being proportional to a concentration of ketone in the fluid; and correlating the first signal to the concentration of glucose in the fluid and the second signal to the concentration of ketone in the fluid.

[0089] Element 1': Wherein the first part is multi-component and comprises at least a first membrane polymer and a second membrane polymer that are different from each other. Element 2': The second portion is homogeneous and comprises one of the first membrane polymer and the second membrane polymer.

[0090] Element 3': Here, the first part comprises at least two membrane layers. Element 4': Here, a first membrane polymer is disposed directly over the ketone-responsive active area, and a second membrane polymer is disposed over the first membrane polymer and the glucose-responsive active area.

[0091] Element 5': Here, the first portion of the membrane is thicker than the second portion of the membrane. Element 6': Here, a first portion of the membrane comprises polyvinylpyridine and polyvinylpyridine-co-styrene, and a second portion of the membrane comprises polyvinylpyridine-co-styrene.

[0092] Element 7': Here, the first portion of the membrane comprises a mixture of a first membrane polymer and a second membrane polymer. Element 8': Here, the first and second portions define a continuous membrane that covers the ketone and glucose responsive active areas.

[0093] Element 9': The sensor tail is configured for insertion into tissue. Element 10': Wherein the glucose-responsive active region and the ketone-responsive active region each comprise an electron transfer agent covalently attached to a polymer in each of the glucose-responsive active region and the ketone-responsive active region.

[0094] Element 11': Wherein the glucose-responsive enzyme is covalently bound to the polymer at a glucose-responsive active region and one or more of the at least two enzymes of the enzyme system is covalently bound to the polymer at a ketone-responsive active region.

[0095] Element 12': The fluid is a biological fluid and the analyte sensor is exposed to the biological fluid in vivo. Element 13': Here, the first signal and the second signal are measured at different times. Element 14': Here, the first signal and the second signal are acquired simultaneously via the first channel and the second channel.

[0096] As non-limiting examples, exemplary combinations applicable to A' and B' include: 1' and 2'; 1' and 3'; 1',3',4'; 1'-4'; 1' and 5'; 1' and 6'; 1' and 7'; 1' and 8'; 1' and 9'; 1' and 10'; 1' and 11'; 2' and 3'; 3' and 4'; 2'-4'; 3' and 5'; 3' and 6'; 3' and 7'; 3' and 8'; 3' and 9'; 3' and 10'; 3' and 11'; 3'-5'; 3',4' ,6';3' and 4';3',4',';3',4',9';3',4',10';3',4',11';6' and 7';7' and 8';7' and 9';7' and 10';7' and 11';8' and 9';8' and 10';8' and 11';10' and 11', any of which may be further combined with elements 12', 13', and 14'. Other exemplary combinations applicable to B' include any one of elements 1'-11' in combination with one or more of element 12', element 13' or element 14', element 13' or element 14'; 12' and 13'; and 12' and 14'.

[0097] To facilitate a better understanding of the embodiments described herein, the following examples of various representative embodiments are given, which are not intended to limit or define the scope of the invention.

[0098] (Example) A poly(vinylpyridine)-coordinated transition metal complex has been prepared having the structure shown in Formula 1. Further details regarding this transition metal complex and electron transfer therewith are provided in commonly owned U.S. Patent No. 6,605,200, incorporated by reference above. The subscripts for each monomer represent exemplary atomic ratios and do not indicate a particular monomer order.

[0099] [ka] Example 1: Detection of ketones using an analyte sensor having diaphorase and β-hydroxybutyrate dehydrogenase acting in concert. In this example, the enzyme system of FIG. 2A was used to facilitate the detection of ketones. The spotting formulations shown in Table 1 below were coated onto a carbon working electrode. Each spot was coated approximately 0.01 mm onto the working electrode. 2 Deposition was performed to lay down six regions with an area of ​​100 μm. After deposition, the working electrode was cured overnight at 25 °C. A homogenous PVP film was then attached to the working electrode via dip coating using a coating solution formulated with 4 mL of 100 mg / mL PVP, 0.2 mL of 100 mg / mL PEGDGE400 (PEGDGE with a molecular weight of approximately 400), and 0.0132 mL of 100 mg / mL polydimethylsiloxane (PDMS). The film was cured in a dry vial at 25 °C for 24 h, followed by 56 °C for 48 h.

[0100] [Table 1] Ketone analysis was performed by immersing the electrode in 100 mM PBS buffer (pH = 7.4) at 33 °C and injecting various amounts of β-hydroxybutyrate as a ketone surrogate (a total of 0, 1, 2, 3, 4, 6, and 8 mM β-hydroxybutyrate was added). +FIG. 6 shows four replicates of the response of an electrode containing β-hydroxybutyrate dehydrogenase and β-hydroxybutyrate dehydrogenase upon exposure to various β-hydroxybutyrate concentrations. There are only two traces in FIG. 6 due to overlapping signal responses for the four sensors tested. As shown, the current response increased for several minutes after exposure to a new β-hydroxybutyrate concentration before stabilizing thereafter. FIG. 7 shows an exemplary plot of the average current response of the electrode in FIG. 6 versus β-hydroxybutyrate concentration. The ketone sensor showed a stable response even over extended periods of measurement, as shown in FIG. 8. FIG. 8 shows an exemplary plot of the current response of the electrode in FIG. 6 upon exposure to 8 mM β-hydroxybutyrate in 100 mM PBS at 33° C. for two weeks. The average signal loss over the measurement period was only 3.1%.

[0101] Example 2: Detection of glucose and ketones using an analyte sensor having glucose-responsive active areas and ketone-responsive active areas on separate working electrodes. In this example, an analyte sensor was prepared with a glucose-responsive active region containing glucose oxidase deposited on a first working electrode and a ketone-responsive active region containing diaphorase and β-hydroxybutyrate dehydrogenase deposited on a second working electrode. The two working electrodes were carbon electrodes disposed on opposite sides of a planar dielectric substrate.

[0102] Glucose-responsive active areas were deposited on the first working electrode using the glucose oxidase formulations specified in Table 2 below. The active area deposits were each approximately 0.01 mm 2 This was performed by placing five separate areas with an area of ​​100 nm on the working electrode. After deposition, the working electrode was cured overnight at 25° C.

[0103] [Table 2] A ketone-responsive active area was deposited on the second working electrode using the diaphorase / β-hydroxybutyrate formulation specified above in Table 1. Deposition and curing of the active area was carried out as in Example 1 above, except in this case, five detection areas were deposited. Curing of the ketone-responsive active area and the glucose-responsive active area was carried out simultaneously.

[0104] Following the deposition of the active area, a bilayer film was deposited on the ketone-responsive active area as follows: A PVP film was first deposited on the ketone-responsive active area by a modified slot-coating method. The PVP film in this example was deposited from a coating solution formulated with 4 mL of 160 mg / mL PVP, 0.133 mL of 100 mg / mL PEGDGE400, and 0.0132 mL of 100 mg / mL PDMS. Curing was then carried out at 25° C. for 24 hours. The slot-coating procedure was carried out by pumping the coating solution through a nozzle slightly above the row of sensor tails using a syringe pump. The coating solution was pumped at a constant rate while moving the nozzle at a constant speed across the row of sensor tails. Parameters such as flow rate, nozzle diameter, nozzle movement speed, distance between the nozzle and the sensor tail, solution viscosity, temperature, and solvent were varied to obtain a film with the desired thickness.

[0105] The entire assembly (i.e., both working electrodes, the PVP coating on the working electrodes including the glucose-responsive active area, the ketone-responsive active area, and the counter and reference electrodes) was then dip-coated to introduce a cross-linked polyvinylpyridine-co-styrene membrane polymer thereon. The membrane polymer coating the entire assembly was deposited using 4 mL of polyvinylpyridine-co-styrene in 80:20 ethanol:HEPES buffer (140 mg / mL), 0.2 mL PEGDGE400 in 80:20 ethanol:HEPES buffer (100 mg / mL), and 0.0132 mL of aminopropyl-terminated polydimethylsiloxane (PDMS) in ethanol (100 mg / mL). Curing was again carried out at 25 °C for 24 h, followed by 48 h at 56 °C in a dry environment. Thus, a homogeneous membrane (polyvinylpyridine-co-styrene) was deposited on the glucose-responsive active area, and a bilayer membrane (an inner layer of PVP and an outer layer of polyvinylpyridine-co-styrene) was deposited on the ketone-responsive active area.

[0106] The analyte sensor was used to simultaneously assay glucose and ketones in 100 mM PBS at 37°C. In the first experiment, the sensor was exposed to a 100 mM PBS solution containing 30 mM glucose and 10 mM β-hydroxybutyrate (a ketone surrogate) for 2 weeks at 37°C. In this experiment, the sensor was held at +40 mV vs. Ag / AgCl. Figure 9 shows an exemplary plot of the response of an analyte sensor containing glucose-responsive active regions and ketone-responsive active regions located on separate working electrodes after exposure to 30 mM glucose and 10 mM ketone. As shown, the response of the analyte sensor remained highly stable over the observation period for both analytes.

[0107] Next, glucose and β-hydroxybutyrate were added stepwise to 100 mM PBS at 37 °C to determine the response of the analyte sensor to each analyte. In this experiment, the sensor was again held at +40 mV vs. Ag / AgCl. Glucose was added in a concentration range of 0-30 mM, and β-hydroxybutyrate was added in a concentration range of 0-10 mM. Each analyte was added simultaneously at concentrations up to 10 mM. Above 10 mM, only additional glucose was added to the solution, with 10 mM representing the maximum ketone concentration tested. Figures 10-12 show plots of the analyte sensor response to various concentrations of glucose and β-hydroxybutyrate. As shown in Figures 10,11, the analyte sensor provided a linear response to both analytes over the concentration range tested. As shown in Figure 12, the sensor response was rapid for both analytes and remained stable at a given analyte concentration.

[0108] Example 3: Detection of ketones using an analyte sensor with NADH oxidase and β-hydroxybutyrate dehydrogenase acting in concert. In this example, the enzyme system of FIG. 2B was used to facilitate the detection of ketones. The spotting formulations shown in Table 3 below were coated onto either the carbon working electrode or the carbon nanotube working electrode. Coating was done manually in three passes to coat the entire sensor chip. The average active area was 3.0 mm2 for the carbon working electrode. 2 , 7.6 mm for carbon nanotube working electrode 2 After deposition, the working electrode was cured overnight at 25°C. A PVP film was then attached to the working electrode via dip coating using a coating solution formulated with 4 mL of 100 mg / mL PVP and 0.2 mL of 100 mg / mL PEGDGE400. The film was then cured at 25°C for 24 hours.

[0109] [Table 3] Ketone analysis was performed as described in Example 1.

[0110] 13A and 13B show the NADHO x , N.A.D. + 13A and 13B are graphs showing four replicates of the response of an electrode containing β-hydroxybutyrate dehydrogenase. FIG. 13A shows the current response of a carbon working electrode, and FIG. 13B shows the current response of a carbon nanotube working electrode. As shown, the current response of both types of working electrodes increased as the β-hydroxybutyrate concentration increased up to a concentration of 10 mM.

[0111] FIG. 14 shows the effect of exposure to increasing concentrations of β-hydroxybutyrate dehydrogenase on NADHO x , N.A.D. + 1 shows an exemplary plot of current response versus time for an electrode containing β-hydroxybutyrate dehydrogenase and β-hydroxybutyrate dehydrogenase. As shown, the current increased rapidly after the addition of β-hydroxybutyrate dehydrogenase and then stabilized.

[0112] Example 4: Detection of ketones using an analyte sensor containing poly-1,10-phenanthroline-5,6-dione and β-hydroxybutyrate dehydrogenase. In this example, the enzyme system of FIG. 2C was used to facilitate the detection of ketones. The spotting formulations shown in Table 3 below were coated onto either a carbon working electrode or a carbon nanotube working electrode. Coating and curing of the spotting formulations and PVP films were performed as specified in Example 3. The average active area was 3.0 mm on the carbon working electrode. 2 , 7.6 mm for carbon nanotube working electrode 2 It was.

[0113] [Table 4] Ketone analysis was performed as described in Example 1. Figures 15A and 15B show four replicates of the response of an electrode containing poly-1,10-phenanthroline-5,6-dione and β-hydroxybutyrate dehydrogenase when exposed to various β-hydroxybutyrate concentrations. Figure 15A shows the current response of a carbon working electrode, and Figure 15B shows the current response of a carbon nanotube working electrode. As shown, the current response of both types of working electrodes increased as the β-hydroxybutyrate concentration increased up to a concentration of about 2 mM before the response began to plateau.

[0114] (Analyte Sensor Ignition Lock) Vehicle fail-safes, such as ignition locks, may be used to prevent a driver from operating a vehicle when impaired or in an unsafe condition to operate the vehicle. Operating a vehicle while impaired can pose serious danger to the driver and the public. One common type of ignition lock is designed to prevent drunk driving, specifically to prevent an individual from operating a vehicle while intoxicated by the use of alcohol. Such locking devices connect a breath alcohol analyzer or optical sensor to the vehicle's ignition system and require the driver to pass a blood alcohol concentration test before starting the vehicle.

[0115] Intoxication is one type of impairment or condition a driver may experience that renders them unfit or unable to operate a vehicle. However, other impairments and conditions may also adversely affect a driver and must be closely monitored to ensure that drivers do not operate a vehicle while impaired. For example, a driver who is driving with hypoglycemia (low blood sugar levels) due to diabetes may experience lightheadedness, confusion, headaches, loss of consciousness, seizures, and slowed reflexes, any of which may endanger their life or the life of anyone in or near the vehicle.

[0116] Analyte monitoring systems have been developed to facilitate long-term monitoring of analytes in bodily fluids (such as blood). Some analyte monitoring systems are designed to detect and monitor blood glucose levels, aiding in the treatment of diabetic conditions. However, other analyte monitoring systems are designed to detect and monitor other analytes present in the driver's bodily fluids, and abnormal analyte levels detected in the driver may indicate that the driver is currently unfit to safely operate a vehicle.

[0117] The following description describes an analyte monitoring and vehicle control system used to prevent operation of the vehicle when the driver's analyte levels exceed a predetermined threshold. By properly deploying the sensor control device 102 (FIG. 1), the user can intelligently track and monitor bodily fluid analyte levels and trends. When some analyte levels exceed a certain threshold, physical or cognitive impairment may occur that may prevent the user from safely operating the vehicle. In such cases, the user must take appropriate measures to bring the analyte levels back into a safe range before attempting to operate the vehicle. However, in some cases, the user may feel perfectly fine to operate the vehicle, but there are unsafe analyte levels that may suddenly cause the onset of a dangerous physical impairment. In such cases, it may be advantageous to install a fail-safe system that prevents or warns the user from operating the vehicle and potentially endangering themselves or others.

[0118] 16 is a schematic diagram of an exemplary analyte monitoring and vehicle control system 1600 in accordance with one or more embodiments of the present disclosure. As shown, the analyte monitoring and vehicle control system 1600 (hereinafter "system 1600") includes a sensor control device 102 that can be deployed on a user or "driver" 3202 or otherwise delivered to a target monitoring location on the body, such as the back of the driver's 1602 arm. As described above, the sensor control device 102 includes a sensor 104 (FIG. 1) that, when properly deployed, is transdermally placed within the skin to detect and monitor analytes present in the bodily fluids of the driver 1602. An adhesive patch 105 (FIG. 1) applied to the bottom of the sensor control device 102 adheres to the skin to secure the sensor control device 102 in place during operation.

[0119] Although system 1600 is described herein as including an on-body sensor control device 102 for detecting and reporting analyte levels, system 1600 could instead incorporate an external analyte sensor (e.g., a self-monitoring blood glucose "SMBG" meter) without departing from the scope of the disclosure. Thus, the term "sensor control device" should be construed herein to generally include on-body sensor systems as described above, as well as traditional handheld sensor systems.

[0120] As shown, the system 1600 may further include a reading device 120, with which the sensor control device 102 may communicate via a local communication path or link to provide analyte concentration data automatically, periodically, or when desired by the driver 1602. The reading device 120 communicates with a control module 1604, which communicates with an electrical system of the vehicle 1606 and is powered by the vehicle battery or otherwise by a separate battery. In such an embodiment, data transmitted from the sensor control device 102 to the reading device 120 may then be transmitted by the reading device 120 to the control module 1604 for processing. However, in other embodiments, the sensor control device 102 may directly communicate with the control module 1604 via any wireless communication protocol, such as BLUETOOTH. In such an embodiment, the reading device 120 may or may not be required in the system 1600.

[0121] In the illustrated embodiment, vehicle 1606 is depicted as an automobile. However, as used herein, the term "vehicle" is used broadly and is meant to include any type of transportation vehicle that can be operated by a human user or "driver," but may also include autonomous vehicles used to transport humans. Examples of vehicle 1606 include, but are not limited to, any type of automobile, truck, sport utility vehicle, aircraft, watercraft, spacecraft, and / or any other mode of transportation, or combinations thereof.

[0122] The control module 1604 may include a communication interface for communicating information with the sensor control device 102 and / or the reading device 120. In the case of an exemplary BLUETOOTH enabled sensor control device 102 and / or reading device 120, when the sensor control device 102 approaches the vehicle 1606, it may enter a pairing mode. During pairing, the control module 1604 may be programmed and configured to automatically detect the presence of the sensor control device 102 and / or the reading device 120 and establish communication therewith. For example, when the driver 1602 approaches or enters the vehicle 1606, the control module 1604 may automatically detect the presence of the sensor control device 102 and / or the reading device 120 and initiate communication therebetween or with the reading device 120.

[0123] In some embodiments, the control module 1604 may communicate with a vehicle user interface 1608 included in the vehicle 1606, such as an infotainment system, a touch screen display, or an information display. In such embodiments, the control module 1604 may visually interact with the driver 1602 via the vehicle user interface 1608 and may also audibly interact with the driver 1602 via an audio speaker included in the vehicle 1606. However, in other embodiments, the control module 1604 may be configured to communicate with the reading device 120 such that it may communicate with the driver 1602.

[0124] As shown, the control module 1604 may be or may otherwise include a computer system 1610 configured and otherwise programmed to control various operations and / or systems of the vehicle 1606 based on the driver's 1602 real-time measured analyte levels obtained by the sensor control device 102. The operation of the vehicle 1606 may be controlled, disabled, or modified by disabling one or more critical systems of the vehicle 1606 or by activating warning systems within the vehicle 1606. If the driver's 1602 real-time measured analyte levels are within a predetermined safe range, it may be deemed safe for the driver 1602 to operate the vehicle 1606. However, if the driver's 1602 real-time measured analyte levels are outside a predetermined safe range or exceed a predetermined threshold, the computer system 1610 may be programmed to control, disable, or modify the operation of the vehicle 1606.

[0125] In some embodiments, for example, the computer system 1610 may be configured to disable various critical vehicle systems when the driver's 1602 detected analyte levels are outside of a predetermined range or exceed a predetermined threshold, thereby progressively and safely disabling operation of the vehicle upon identifying the driver 1602 as impaired for safe operation of the vehicle 1606. Critical vehicle systems of the vehicle 1606 that may be disabled include the ignition system (e.g., energy switching / control system), transmission system (or gearbox), fuel system, energy supply system (e.g., battery, capacitor, conversion / reaction cell, etc.). When elevated or reduced (unsafe) analyte levels are detected, the computer system 1610 may prevent critical vehicle systems from functioning or operating. As a result, the driver 1602 may not be able to start or operate the vehicle 1606, thereby preventing the driver 1602 from endangering himself and / or others.

[0126] In other embodiments, or in addition, the computer system 1610 may be configured to activate various non-critical vehicle systems when the driver's 1602 detected analyte levels fall outside or exceed predetermined thresholds. Non-critical vehicle systems that may be activated include, for example, a vehicle horn, vehicle lights, or an audible warning system installed in the vehicle 1606. In such embodiments, activation of a non-critical vehicle system may alert law enforcement and others (e.g., drivers of adjacent vehicles, bystanders, pedestrians, etc.) of the driver 1602 who may be operating in an impaired condition, thus enabling law enforcement to quickly address the problem associated therewith and notify others of a potentially dangerous situation.

[0127] In yet other embodiments, or in addition, the computer system 1610 may be configured to automatically call one or more emergency contacts when the driver's 1602 analyte levels are outside of a predetermined safe operating range or otherwise exceed a predetermined threshold. In such embodiments, the computer system 1610 may operate via the reading device 120 (e.g., a cell phone) or a cellular or satellite communication system (e.g., OnStar®) integrated into the vehicle 1606. In other embodiments, or in addition, the computer system 1610 may be configured to automatically send a message (e.g., a text or SMS message, email, etc.) to an emergency contact when the driver's 1602 analyte levels are outside of a predetermined safe operating range or otherwise exceed a predetermined threshold. Examples of emergency contacts include, but are not limited to, a spouse, a parent, a medical professional (e.g., a doctor), a hospital, 911, or any combination thereof.

[0128] In some embodiments, the system 1600 may further include one or more proximity sensors 1612 configured to detect the presence of the driver 1602, and more specifically, the sensor control device 102. In such embodiments, the proximity sensor 1612 may be configured to monitor the general area of ​​the driver's seat 1614 within the vehicle 1606. If the sensor control device 102 is detected within the area of ​​the driver's seat 1614 by the proximity sensor 1612, it may provide a positive indication that the driver 1602 is in the driver's seat 1614 and potentially attempting to operate the vehicle 1606. In such a case, a signal may be sent to the control module 1604 to alert the computer system 1610 that the driver 1602 is in the vehicle 1606 and may be attempting to operate the vehicle 1606. If the driver's 1602 real-time measured analyte levels are within a predetermined safe range or below a predetermined level, the computer system 1610 may allow the driver 1602 to operate the vehicle 1606. However, if the driver's 1602 real-time measured analyte levels are outside of a predetermined safe range or exceed a predetermined threshold, the computer system 1610 may control, disable, or modify operation of the vehicle 1606, generally as described above. As will be appreciated, the proximity sensor 1612 may be advantageous to prevent operation of the vehicle 1606 only if the impaired driver 1602 is in the driver's seat 1614 and ready to operate the vehicle 1606. As a result, a user wearing the sensor control device 102 may ride as a passenger in the vehicle 1606 in any condition without affecting the operation of the control module 1604 or the vehicle 1606.

[0129] In some embodiments, the control module 1604 may further include a vehicle status detection module 1616 configured to detect a current state of the vehicle 1606, including whether the vehicle 1606 is currently moving or stationary. Additionally, the vehicle status detection module 1616 may be configured to determine whether a motor in the vehicle 1606 is currently running or stopped. In one or more embodiments, the vehicle status detection module 1616 may provide a status signal to the control module 1604, and the control module 1604 may use the status signal to determine which vehicle operations to activate or disable if the driver's 1602 analyte levels, as measured in real time, are outside of a predetermined safe range or exceed a predetermined threshold. For example, if the status signal indicates that the vehicle 1606 is stationary, the control module 1604 may disable the vehicle fuel system, the transmission system, the ignition system, or any combination thereof. In contrast, when the status signal indicates that the vehicle 1606 is moving, the control module 1604 may activate the vehicle horn, flash the vehicle lights, or alert the driver 1602 and / or people around the driver 1602 that the driver 1602 is impaired.

[0130] In some embodiments, when the driver 1602 enters the vehicle 1606 or when the control module 1604 is paired with the sensor control device 102 and / or the reading device 120, an app may be launched on the reading device 120 or vehicle user interface 1608 and a digital dashboard may be displayed on the reading device 120 and / or vehicle user interface 1608 showing current analyte levels, trends, historical data, and predicted analyte levels. However, if the current analyte levels are outside of a predetermined safe operating range, the computer system 1610 may be programmed to disable one or more critical vehicle systems to prevent the driver 1602 from operating the vehicle 1606. In such embodiments, a visual or audio warning may be generated by the control module 1604 to inform the driver 1602 as to why the vehicle 1606 will not start. More specifically, a visual alert (e.g., a text message) may be generated and displayed on the reading device 120 or vehicle user interface 1608, or an audible alert (e.g., a voice message) may be transmitted through a speaker in the reading device 120 or vehicle 1606.

[0131] If not done automatically, the driver 1602 may be prompted to obtain current analyte levels upon pairing the sensor control device 102 with the control module 1604. In some cases, the vehicle 1606 may be prevented from being operated until current analyte levels are obtained. If the current analyte levels are within safety limits, the computer system 1610 may allow operation of the vehicle 1606. In some embodiments, and unless done automatically, the control module 1604 may prompt the driver 1602 to obtain additional current analyte levels after operating the vehicle 1606 for a predetermined period of time (e.g., after 1 hour, 2 hours, 5 hours, etc.).

[0132] In some embodiments, the control module 1604 may be configured to issue visual or audio recommendations or coaching to the driver 1602 that may assist in returning the measured analyte levels to a safe range. In such embodiments, such visual or audio recommendations may prompt the user to take some action that may result in returning the analyte levels to a safe range. Additionally, in some embodiments, the driver 1602 may be able to verbally communicate with the control module 1604 by issuing verbal responses or commands. This may prove advantageous in helping to prevent distracted operation of the vehicle 1606.

[0133] In some embodiments, the settings of the control module 1604 may be customized by the driver 1602 to allow the user to make an informed decision after an unsafe analyte level is detected and a visual or audio warning is generated by the control module 1604. More particularly, in at least one embodiment, the control module 1604 may include a bypass feature that may allow the driver 1602 to operate the vehicle 1606 even when an unsafe analyte level is measured. In such an embodiment, the driver 1602 may operate the vehicle 1606 by acknowledging that the driver 1602 may be operating the vehicle 1606 with an impaired or unsafe health condition.

[0134] In some embodiments, the computer system 1610 may be configured or programmed to calculate a predictive timeline when the driver's 1602 analyte levels may deviate from a predefined safe range or otherwise exceed a predefined threshold. In such embodiments, the control module 1604 may be configured to generate a visual or audio warning to the driver 1602 indicating approximately how much time the driver 1602 has before reaching an unsafe analyte level and potentially dangerous medical conditions may result. Multiple warnings may be provided to indicate that the driver has certain time increments remaining before reaching an unsafe analyte level. For example, a visual or audio warning may be generated when an unsafe analyte level is reached within 1 hour, within 30 minutes, within 10 minutes, within 5 minutes, within 1 minute, and any time increment therebetween. Additionally, a visual or audio warning may be generated when the driver's analyte levels reach a dangerous level or exceed a predefined threshold.

[0135] In some embodiments, if an unsafe analyte level is measured while the driver 1602 is operating the vehicle 1606, the control module 1604 may be configured to generate one or more warnings (visual or audible) to alert the driver 1602 of the unsafe analyte level. In some cases, the volume of a stereo in the vehicle 1606 may be automatically lowered so that the driver 1602 can hear the audible warning. In such embodiments, the control module 1604 may be configured to suggest one or more corrective actions to the driver 1602. Examples of corrective actions include, but are not limited to, slowing and stopping the vehicle 1606, locating and driving to a nearby convenience store or pharmacy, and locating a nearby hospital or medical facility. If the vehicle 1606 is an autonomous vehicle and the current analyte level places the driver 1602 in a potentially unsafe condition, the control module 1604 may automatically direct the vehicle 1606 to a medical facility for treatment. Alternatively, or in addition, the control module 1604 can gradually slow or limit the speed of the vehicle 1606 when an unsafe analyte level is detected, thus stopping the driver 1602 and correcting the problem before continuing to operate the vehicle 1606.

[0136] The system 1600 may be useful in several different scenarios to protect the driver 1602 and / or those around the driver 1602 while driving. In some applications, the system 1600 may be voluntarily implemented by the driver to detect impairments in real time. In other applications, the system 1600 may be required by the owner of the vehicle 1606 to detect impairments of the driver 1602. In such applications, the owner of the vehicle 1606 may be a transportation or trucking company. In still other applications, the system 1600 may be legally required of the driver 1602 to detect impairments.

[0137] Embodiments disclosed herein include the following. E. An analyte monitoring and vehicle control system comprising a sensor control device having a sensor for detecting and monitoring one or more analytes present in a driver's body, and a control module in communication with the sensor control device and the vehicle's electrical system, the control module having a computer system programmed to receive and process data provided by the sensor control device, wherein operation of the vehicle is controlled or disabled by the computer system when the driver's real-time measured analyte levels exceed a predetermined safe threshold.

[0138] F. A method comprising the steps of detecting and monitoring one or more analytes present in a driver's body using a sensor control device having a sensor, receiving and processing data provided by the sensor control device with a control module in communication with the sensor control device and the vehicle's electrical system, and controlling or disabling operation of the vehicle using a computer system of the control module when the driver's real-time measured analyte levels exceed a predetermined safe threshold.

[0139] Each of embodiments E and F may have one or more of the following additional elements in any combination: Element 1: wherein the sensor control device is coupled to the driver, and the sensor is transdermally placed under the skin of the driver to detect and monitor an analyte present in the driver's bodily fluids. Element 2: wherein the sensor control device includes an external analyte sensor. Element 3: further comprising a reading device that receives data from the sensor control device and transmits the data to the control module. Element 4: wherein the vehicle includes a transportation vehicle selected from the group consisting of an automobile, an autonomous vehicle, a truck, a sports utility vehicle, an aircraft, a watercraft, a spacecraft, or any combination thereof. Element 5: wherein the sensor control device is paired with the control module for communication when the driver approaches the vehicle. Element 6: further comprising a vehicle user interface included in the vehicle and in communication with the control module. Element 7: wherein operation of the vehicle is disabled by disabling one or more critical systems of the vehicle, the critical systems being selected from the group consisting of an ignition system, a transmission system, a fuel system, and an energy supply system. Element 8: The operation of the vehicle is controlled by at least one of activating one or more non-critical systems of the vehicle, calling or sending a message to one or more emergency contacts, and gradually reducing the speed of the vehicle. Element 9: The control module further comprises one or more proximity sensors installed in the vehicle to monitor a driver's cab area and detect the presence of the driver. Element 10: Here, the control module further comprises a vehicle status detection module that detects a current state of the vehicle. Element 11: Here, the control module generates a visual or audible warning perceptible by the driver when the driver's real-time measured analyte level is outside of a predetermined safety threshold. Element 12: The visual or audible warning is generated at a specific time increment before the unsafe analyte level is reached. Element 13: The visual or audible warning includes one or more suggested corrective actions that are communicated to the driver. Element 14: Here, the control module includes a bypass function that allows the driver to operate the vehicle when the driver's real-time measured analyte level exceeds a predetermined threshold.

[0140] Element 15: further comprising receiving data from the sensor control device and transmitting the data to the control module using a reading device in communication with the sensor control device and the control module. Element 16: disabling the operation of the vehicle includes disabling one or more critical systems of the vehicle, the critical systems being selected from the group consisting of an ignition system, a transmission system, a fuel system, and an energy supply system. Element 17: wherein controlling the operation of the vehicle includes at least one of activating one or more non-critical systems of the vehicle, calling or sending a message to one or more emergency contacts, and gradually reducing the speed of the vehicle. Element 18: further comprising monitoring a driver's area of ​​the vehicle and detecting the presence of a driver using one or more proximity sensors attached to the vehicle. Element 19: further comprising detecting the current state of the vehicle using a vehicle status detection module included in the control module. Element 20: further comprising generating a visual or audible warning perceivable by the driver using the control module when the driver's real-time measured analyte level exceeds a predetermined threshold.

[0141] Unless otherwise indicated, all numbers expressing quantities and the like in the specification and the associated claims should be understood in all instances to be modified by the term "about." Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by embodiments of the invention. At the very least, and without any attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.

[0142] One or more exemplary embodiments incorporating various features are presented herein. For clarity, not all features of a physical implementation are described or shown in this application. It is understood that in developing a physical embodiment incorporating an embodiment of the invention, numerous implementation-specific decisions must be made to achieve the developer's goals, such as system-related, business-related, government-related, and other compliance. Constraints vary from implementation to implementation and over time. While the developer's efforts may be time-consuming, such efforts are nevertheless routine for those of ordinary skill in the art having the benefit of this disclosure.

[0143] Although various systems, tools, and methods are described herein in terms of "including" various components or steps, the systems, tools, and methods may also be "consisting essentially of" or "consisting of" various components and steps.

[0144] As used herein, the phrase "at least one of" preceding a list of items, together with the terms "and" or "or" separating any of the items, modifies the list as a whole (i.e., each item) and not each member of the list. The phrase "at least one of" allows for the meaning to include at least one of any one of the items, and / or at least one of any combination of the items, and / or at least one of each of the items. By way of example, the phrase "at least one of A, B, and C" or "at least one of A, B, or C" refers, respectively, to A only, B only, or C only, any combination of A, B, and C, and / or at least one of each of A, B, and C.

[0145] Thus, the disclosed systems, tools, and methods are well adapted to achieve the objects and advantages mentioned, as well as those inherent therein. The specific embodiments disclosed above are merely illustrative, as the teachings of the present invention may be modified and implemented in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Moreover, no limitations are intended to the details of construction or design shown herein, except as set forth in the appended claims. It is therefore apparent that the specific exemplary embodiments disclosed above may be altered, combined, or modified, and all such variations are considered to be within the scope of the present invention. The systems, tools, and methods illustratively disclosed herein may be suitably practiced in the absence of elements not specifically disclosed herein and / or any elements disclosed herein. Although the systems, tools, and methods are described in terms of "comprising," "including," or "comprising" various elements or steps, the systems, tools, and methods may also "consist essentially of" or "consist of" various elements. All numbers and ranges disclosed above may vary to some extent. Whenever a numerical range with a lower and upper limit is disclosed, any number and any included range within that range is specifically disclosed. In particular, all range values ​​disclosed herein (in the form of "about a to about b", or equivalently "about a to b", or equivalently "about a b") should be understood as follows: all numbers and ranges falling within the broader range value; and claim terms have their plain and ordinary meaning unless expressly and unambiguously defined by the patent owner. Furthermore, the indefinite article "a" or "an" as used in the claims is defined herein to mean one or more elements that it introduces. In the event of a discrepancy in the use of a term or term in this specification and one or more patents or other documents that may be incorporated herein by reference, the definition consistent with this specification should be adopted.

Claims

1. An analyte sensor for detecting glucose and ketones in vivo, comprising: a first working electrode; a second working electrode; and a ketone-responsive active area disposed on a surface of the first working electrode; a glucose-responsive active area disposed on a surface of the second working electrode; a diffusion-limiting barrier, a first membrane disposed over the ketone-responsive active area; a second membrane disposed over the first membrane and the glucose-responsive active region; and a diffusion-limiting barrier comprising Equipped with the first membrane and the second membrane have different permeability values ​​for differentially regulating analyte flux in the ketone-responsive active region and the glucose-responsive active region; The analyte sensor is configured to be partially inserted into a user's skin such that a distal portion of the sensor contacts a fluid for detecting glucose and ketones in vivo.

2. The analyte sensor of claim 1, wherein the first membrane and the second membrane have different compositions to provide different permeability values ​​for differentially regulating analyte flux in the ketone-responsive active region and the glucose-responsive active region.

3. An analyte sensor as described in claim 1 or 2, wherein the diffusion-limiting barrier has different thicknesses in the ketone-responsive active region and the glucose-responsive active region.

4. An analyte sensor described in any one of claims 1 to 3, wherein the diffusion-limiting barrier is a dip-coated membrane.

5. An analyte sensor described in any one of claims 1 to 3, wherein the diffusion-limiting barrier is a printed membrane.

6. An analyte sensor described in any one of claims 1 to 5, wherein the glucose-responsive active region and the ketone-responsive active region are laterally spaced apart from each other along the distal portion of the sensor.

7. An analyte sensor described in any one of claims 1 to 6, wherein the first working electrode is a first carbon working electrode and the second working electrode is a second carbon working electrode.

8. An analyte sensor described in any one of claims 1 to 7, wherein the first membrane comprises a first membrane polymer.

9. An analyte sensor described in any one of claims 1 to 8, wherein the first membrane is homogeneous.

10. The analyte sensor of claim 8, wherein the second membrane comprises the first membrane polymer and a second membrane polymer different from the first membrane polymer.

11. The analyte sensor of claim 1, wherein the first working electrode and the second working electrode are substantially planar.

12. An analyte sensor according to any one of claims 1 to 11, further comprising a substrate.

13. The analyte sensor of claim 12, wherein the first working electrode and the second working electrode are disposed on at least one surface of the substrate.

14. The analyte sensor of claim 12, wherein the substrate is a planar dielectric substrate.

15. An analyte sensor according to any one of claims 1 to 14, further comprising a reference electrode and a counter electrode.

16. The analyte sensor of claim 15, further comprising a first dielectric layer disposed on the reference electrode and a second dielectric layer disposed on the reference electrode.

17. A method for detecting glucose and ketones in vivo, comprising: exposing the analyte sensor of any one of claims 1 to 16 to a fluid containing glucose and / or ketones; applying a potential to the first working electrode and the second working electrode; obtaining a first signal at or above the redox potential of the glucose-responsive active region, the first signal being proportional to the concentration of glucose in the fluid; obtaining a second signal at or above the redox potential of the ketone-responsive active region, the second signal being proportional to the concentration of ketone in the fluid; correlating the first signal to the concentration of glucose in the fluid and correlating the second signal to the concentration of ketones in the fluid; A method comprising:

18. The method of claim 17, wherein the fluid is a biological fluid and the analyte sensor is exposed to the biological fluid in vivo.

19. A method as described in claim 17 or 18, wherein the first signal and the second signal are measured at different times.

20. A method as described in claim 17 or 18, wherein the first signal and the second signal are acquired simultaneously via a first channel and a second channel.

21. A method described in any one of claims 17 to 20, wherein the biological fluid is interstitial fluid.

22. A sensor control device, (i) sensor electronics; (ii) the sensor of any one of claims 1 to 16, acquiring a first signal indicative of a ketone concentration and a second signal indicative of a glucose concentration, and communicating the first and second signals to the sensor electronics; A sensor control device comprising:

23. The sensor control device of claim 22, wherein the sensor electronics are configured to correlate the first signal to a ketone concentration.

24. A sensor control device as described in claim 22 or 23, wherein the sensor electronics are configured to correlate the second signal with a glucose concentration.

25. A glucose and ketone detection system comprising: (i) sensor electronics; (ii) the sensor of any one of claims 1 to 16, acquiring a first signal indicative of a ketone concentration and a second signal indicative of a glucose concentration, and communicating the first and second signals to the sensor electronics; Equipped with The glucose and ketone detection system, wherein the sensor electronics are configured to (a) correlate the first signal acquired by the sensor to a ketone concentration, (b) correlate the second signal acquired by the sensor to a glucose concentration, and (c) communicate the ketone concentration and the glucose concentration to a reading device for display.

Images